"Journal Data Filtered By:  Selected Categories: CARDIAC & CARDIOVASCULAR SYSTEMS;RESPIRATORY SYSTEM;REHABILITATION;ONCOLOGY Selected Editions: SCIE;SSCI;AHCI;ESCI Selected JCR Year: 2024 Selected Category Schema: WOS Selected Open Access: N Indicator: Default"

Journal name,JCR Abbreviation,Publisher,ISSN,eISSN,Category,Edition,Total Citations,2024 JIF,JIF Quartile,2024 JCI,% of Citable OA
"CA-A CANCER JOURNAL FOR CLINICIANS","CA-CANCER J CLIN","WILEY","0007-9235","1542-4863","ONCOLOGY","SCIE","71,799","232.4","Q1","120.89","100"%,
"Nature Reviews Clinical Oncology","NAT REV CLIN ONCOL","NATURE PORTFOLIO","1759-4774","1759-4782","ONCOLOGY","SCIE","33,355","83.2","Q1","12.02","1.49"%,
"NATURE REVIEWS CANCER","NAT REV CANCER","NATURE PORTFOLIO","1474-175X","1474-1768","ONCOLOGY","SCIE","60,054","66.8","Q1","9.04","1.36"%,
"ANNALS OF ONCOLOGY","ANN ONCOL","ELSEVIER","0923-7534","1569-8041","ONCOLOGY","SCIE","64,093","65.4","Q1","8.36","33.87"%,
"CANCER CELL","CANCER CELL","CELL PRESS","1535-6108","1878-3686","ONCOLOGY","SCIE","56,241","44.5","Q1","8.07","31.56"%,
"Nature Reviews Cardiology","NAT REV CARDIOL","NATURE PORTFOLIO","1759-5002","1759-5010","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","22,153","44.2","Q1","8.35","3.38"%,
"JOURNAL OF CLINICAL ONCOLOGY","J CLIN ONCOL","LIPPINCOTT WILLIAMS & WILKINS","0732-183X","1527-7755","ONCOLOGY","SCIE","169,483","43.4","Q1","6.77","24.89"%,
"Journal of Hematology & Oncology","J HEMATOL ONCOL","BMC","N/A","1756-8722","ONCOLOGY","SCIE","27,071","40.4","Q1","5.05","100"%,
"CIRCULATION","CIRCULATION","LIPPINCOTT WILLIAMS & WILKINS","0009-7322","1524-4539","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","177,978","38.7","Q1","9.12","14.07"%,
"LANCET ONCOLOGY","LANCET ONCOL","ELSEVIER SCIENCE INC","1470-2045","1474-5488","ONCOLOGY","SCIE","74,077","35.9","Q1","8.62","14.58"%,
"EUROPEAN HEART JOURNAL","EUR HEART J","OXFORD UNIV PRESS","0195-668X","1522-9645","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","90,583","35.7","Q1","8.41","27"%,
"Molecular Cancer","MOL CANCER","BMC","N/A","1476-4598","ONCOLOGY","SCIE","42,332","33.9","Q1","5.04","100"%,
"Cancer Discovery","CANCER DISCOV","AMER ASSOC CANCER RESEARCH","2159-8274","2159-8290","ONCOLOGY","SCIE","36,517","33.3","Q1","6","38.46"%,
"Lancet Respiratory Medicine","LANCET RESP MED","ELSEVIER SCI LTD","2213-2600","N/A","RESPIRATORY SYSTEM","SCIE","22,960","32.8","Q1","8.85","17.18"%,
"Nature Cancer","NAT CANCER","NATURE PORTFOLIO","N/A","2662-1347","ONCOLOGY","SCIE","10,654","28.5","Q1","5.34","33.53"%,
"Cancer Communications","CANCER COMMUN","WILEY","N/A","2523-3548","ONCOLOGY","SCIE","6,881","24.9","Q1","3.66","100"%,
"JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY","J AM COLL CARDIOL","ELSEVIER SCIENCE INC","0735-1097","1558-3597","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","117,273","22.3","Q1","5.1","19.03"%,
"EUROPEAN RESPIRATORY JOURNAL","EUR RESPIR J","EUROPEAN RESPIRATORY SOC JOURNALS LTD","0903-1936","1399-3003","RESPIRATORY SYSTEM","SCIE","54,382","21.2","Q1","4.28","30.94"%,
"Journal of Thoracic Oncology","J THORAC ONCOL","ELSEVIER SCIENCE INC","1556-0864","1556-1380","ONCOLOGY","SCIE","27,302","20.8","Q1","4.24","22.07"%,
"Journal of Thoracic Oncology","J THORAC ONCOL","ELSEVIER SCIENCE INC","1556-0864","1556-1380","RESPIRATORY SYSTEM","SCIE","27,302","20.8","Q1","4.24","22.07"%,
"JAMA Oncology","JAMA ONCOL","AMER MEDICAL ASSOC","2374-2437","2374-2445","ONCOLOGY","SCIE","29,807","20.1","Q1","4.52","23.08"%,
"AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE","AM J RESP CRIT CARE","AMER THORACIC SOC","1073-449X","1535-4970","RESPIRATORY SYSTEM","SCIE","67,431","19.4","Q1","4.39","17.86"%,
"Trends in Cancer","TRENDS CANCER","CELL PRESS","2405-8033","2405-8025","ONCOLOGY","SCIE","9,356","17.5","Q1","2.15","17.59"%,
"CANCER RESEARCH","CANCER RES","AMER ASSOC CANCER RESEARCH","0008-5472","1538-7445","ONCOLOGY","SCIE","118,866","16.6","Q1","2.31","25.93"%,
"Journal of the National Comprehensive Cancer Network","J NATL COMPR CANC NE","HARBORSIDE PRESS","1540-1405","1540-1413","ONCOLOGY","SCIE","14,793","16.4","Q1","2.91","0.46"%,
"CIRCULATION RESEARCH","CIRC RES","LIPPINCOTT WILLIAMS & WILKINS","0009-7330","1524-4571","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","64,140","16.2","Q1","4.13","11.56"%,
"SEMINARS IN CANCER BIOLOGY","SEMIN CANCER BIOL","ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD","1044-579X","1096-3650","ONCOLOGY","SCIE","20,368","15.7","Q1","3.45","23.81"%,
"JACC-Cardiovascular Imaging","JACC-CARDIOVASC IMAG","ELSEVIER SCIENCE INC","1936-878X","1876-7591","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","17,416","15.2","Q1","3.87","20.49"%,
"JAMA Cardiology","JAMA CARDIOL","AMER MEDICAL ASSOC","2380-6583","2380-6591","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","14,345","14.1","Q1","4.05","14.37"%,
"Experimental Hematology & Oncology","EXP HEMATOL ONCOL","BMC","N/A","2162-3619","ONCOLOGY","SCIE","3,391","13.5","Q1","1.95","100"%,
"NEURO-ONCOLOGY","NEURO-ONCOLOGY","OXFORD UNIV PRESS INC","1522-8517","1523-5866","ONCOLOGY","SCIE","24,799","13.4","Q1","3.45","26.27"%,
"JACC: CardioOncology","JACC-CARDIOONCOL","ELSEVIER","2666-0873","2666-0873","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,793","13.4","Q1","2.63","100"%,
"JACC: CardioOncology","JACC-CARDIOONCOL","ELSEVIER","2666-0873","2666-0873","ONCOLOGY","SCIE","2,793","13.4","Q1","2.63","100"%,
"LEUKEMIA","LEUKEMIA","SPRINGERNATURE","0887-6924","1476-5551","ONCOLOGY","SCIE","30,656","13.4","Q1","2.17","57.79"%,
"CARDIOVASCULAR RESEARCH","CARDIOVASC RES","OXFORD UNIV PRESS","0008-6363","1755-3245","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","28,216","13.3","Q1","2.57","38.91"%,
"JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH","J EXP CLIN CANC RES","BMC","N/A","1756-9966","ONCOLOGY","SCIE","28,514","12.8","Q1","2.44","100"%,
"JACC-Heart Failure","JACC-HEART FAIL","ELSEVIER SCI LTD","2213-1779","2213-1787","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","9,430","11.8","Q1","3.07","25.57"%,
"Blood Cancer Journal","BLOOD CANCER J","SPRINGERNATURE","2044-5385","2044-5385","ONCOLOGY","SCIE","8,357","11.6","Q1","2.36","100"%,
"Blood Cancer Discovery","BLOOD CANCER DISCOV","AMER ASSOC CANCER RESEARCH","2643-3230","2643-3249","ONCOLOGY","ESCI","1,370","11.5","Q1","2.83","41.98"%,
"Biomarker Research","BIOMARK RES","BMC","N/A","2050-7771","ONCOLOGY","SCIE","4,951","11.5","Q1","1.67","100"%,
"JACC-Cardiovascular Interventions","JACC-CARDIOVASC INTE","ELSEVIER SCIENCE INC","1936-8798","1876-7605","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","18,003","11.4","Q1","3.01","16.06"%,
"EUROPEAN JOURNAL OF HEART FAILURE","EUR J HEART FAIL","WILEY","1388-9842","1879-0844","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","21,362","10.8","Q1","3.4","40.19"%,
"Nature Cardiovascular Research","NAT CARDIOVASC RES","SPRINGERNATURE","N/A","2731-0590","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,796","10.8","Q1","2.81","32.77"%,
"Cardiovascular Diabetology","CARDIOVASC DIABETOL","BMC","N/A","1475-2840","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","18,535","10.6","Q1","2.5","100"%,
"Journal for ImmunoTherapy of Cancer","J IMMUNOTHER CANCER","BMJ PUBLISHING GROUP","N/A","2051-1426","ONCOLOGY","SCIE","31,330","10.6","Q1","2.15","99.56"%,
"CANCER TREATMENT REVIEWS","CANCER TREAT REV","ELSEVIER SCI LTD","0305-7372","1532-1967","ONCOLOGY","SCIE","12,791","10.5","Q1","1.37","30.07"%,
"European Respiratory Review","EUR RESPIR REV","EUROPEAN RESPIRATORY SOC JOURNALS LTD","0905-9180","1600-0617","RESPIRATORY SYSTEM","SCIE","7,800","10.4","Q1","2.16","99.31"%,
"CLINICAL CANCER RESEARCH","CLIN CANCER RES","AMER ASSOC CANCER RESEARCH","1078-0432","1557-3265","ONCOLOGY","SCIE","92,896","10.2","Q1","2.37","30.29"%,
"CANCER LETTERS","CANCER LETT","ELSEVIER IRELAND LTD","0304-3835","1872-7980","ONCOLOGY","SCIE","42,657","10.1","Q1","2.25","24.55"%,
"Circulation-Arrhythmia and Electrophysiology","CIRC-ARRHYTHMIA ELEC","LIPPINCOTT WILLIAMS & WILKINS","1941-3149","1941-3084","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","9,673","9.8","Q1","2.2","18.38"%,
"EuroIntervention","EUROINTERVENTION","EUROPA EDITION","1774-024X","1969-6213","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,808","9.5","Q1","2.27","0"%,
"Journal of Physiotherapy","J PHYSIOTHER","AUSTRALIAN PHYSIOTHERAPY ASSOC","1836-9553","1836-9561","REHABILITATION","SCIE","3,342","9.4","Q1","2.73","100"%,
"Journal of the National Cancer Center","J NATL CANCER CTR","ELSEVIER","2667-0054","2667-0054","ONCOLOGY","ESCI","965","9.4","Q1","1.75","100"%,
"European Urology Oncology","EUR UROL ONCOL","ELSEVIER","N/A","2588-9311","ONCOLOGY","SCIE","4,058","9.3","Q1","2.44","29.39"%,
"CHEST","CHEST","ELSEVIER","0012-3692","1931-3543","RESPIRATORY SYSTEM","SCIE","50,789","9.2","Q1","2.2","16.89"%,
"ARCHIVOS DE BRONCONEUMOLOGIA","ARCH BRONCONEUMOL","ELSEVIER ESPANA SLU","0300-2896","1579-2129","RESPIRATORY SYSTEM","SCIE","2,677","9.2","Q1","1.57","21.62"%,
"Liver Cancer","LIVER CANCER","KARGER","2235-1795","1664-5553","ONCOLOGY","SCIE","3,280","9.1","Q1","2.08","100"%,
"TRENDS IN CARDIOVASCULAR MEDICINE","TRENDS CARDIOVAS MED","ELSEVIER SCIENCE LONDON","1050-1738","1873-2615","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,437","9","Q1","2.66","20.27"%,
"CANCER AND METASTASIS REVIEWS","CANCER METAST REV","SPRINGER","0167-7659","1573-7233","ONCOLOGY","SCIE","8,047","8.7","Q1","1.18","44.97"%,
"Circulation-Heart Failure","CIRC-HEART FAIL","LIPPINCOTT WILLIAMS & WILKINS","1941-3289","1941-3297","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","10,871","8.5","Q1","2.11","11.4"%,
"Cancer Biology & Medicine","CANCER BIOL MED","CHINA ANTI-CANCER ASSOC","2095-3941","2095-3941","ONCOLOGY","SCIE","3,725","8.4","Q1","0.98","100"%,
"THORAX","THORAX","BMJ PUBLISHING GROUP","0040-6376","1468-3296","RESPIRATORY SYSTEM","SCIE","21,854","8.3","Q1","2.15","36.16"%,
"ESMO Open","ESMO OPEN","ELSEVIER","N/A","2059-7029","ONCOLOGY","SCIE","7,627","8.3","Q1","1.52","97.59"%,
"BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER","BBA-REV CANCER","ELSEVIER","0304-419X","1879-2561","ONCOLOGY","SCIE","11,462","8.3","Q1","1.29","19.96"%,
"Cancer Immunology Research","CANCER IMMUNOL RES","AMER ASSOC CANCER RESEARCH","2326-6066","2326-6074","ONCOLOGY","SCIE","12,853","8.2","Q1","1.82","25.75"%,
"JOURNAL OF CARDIAC FAILURE","J CARD FAIL","CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS","1071-9164","1532-8414","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,593","8.2","Q1","1.77","16.67"%,
"BASIC RESEARCH IN CARDIOLOGY","BASIC RES CARDIOL","SPRINGER HEIDELBERG","0300-8428","1435-1803","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,374","8","Q1","2.18","69.49"%,
"npj Precision Oncology","NPJ PRECIS ONCOL","NATURE PORTFOLIO","N/A","2397-768X","ONCOLOGY","SCIE","4,183","8","Q1","1.69","100"%,
"BREAST","BREAST","CHURCHILL LIVINGSTONE","0960-9776","1532-3080","ONCOLOGY","SCIE","8,178","7.9","Q1","1.82","99.28"%,
"JACC-Clinical Electrophysiology","JACC-CLIN ELECTROPHY","ELSEVIER","2405-500X","2405-5018","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,111","7.7","Q1","2.06","16.7"%,
"NEOPLASIA","NEOPLASIA","ELSEVIER SCIENCE INC","1476-5586","1476-5586","ONCOLOGY","SCIE","8,043","7.7","Q1","1.47","99.04"%,
"npj Breast Cancer","NPJ BREAST CANCER","NATURE PORTFOLIO","N/A","2374-4677","ONCOLOGY","SCIE","4,193","7.6","Q1","1.5","100"%,
"PROGRESS IN CARDIOVASCULAR DISEASES","PROG CARDIOVASC DIS","W B SAUNDERS CO-ELSEVIER INC","0033-0620","1873-1740","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","6,379","7.6","Q1","1.27","16.82"%,
"European Journal of Preventive Cardiology","EUR J PREV CARDIOL","OXFORD UNIV PRESS","2047-4873","2047-4881","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","11,766","7.5","Q1","2.28","28.81"%,
"EUROPACE","EUROPACE","OXFORD UNIV PRESS","1099-5129","1532-2092","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","16,338","7.5","Q1","1.95","66.8"%,
"Circulation-Cardiovascular Interventions","CIRC-CARDIOVASC INTE","LIPPINCOTT WILLIAMS & WILKINS","1941-7640","1941-7632","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,254","7.4","Q1","1.71","14.4"%,
"ONCOGENE","ONCOGENE","SPRINGERNATURE","0950-9232","1476-5594","ONCOLOGY","SCIE","60,082","7.3","Q1","1.5","38.62"%,
"JACC-Basic to Translational Science","JACC-BASIC TRANSL SC","ELSEVIER SCIENCE INC","2452-302X","2452-302X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,274","7.2","Q1","2.06","99.58"%,
"JNCI-Journal of the National Cancer Institute","JNCI-J NATL CANCER I","OXFORD UNIV PRESS INC","0027-8874","1460-2105","ONCOLOGY","SCIE","33,241","7.2","Q1","1.92","25.95"%,
"EUROPEAN JOURNAL OF CANCER","EUR J CANCER","ELSEVIER SCI LTD","0959-8049","1879-0852","ONCOLOGY","SCIE","38,289","7.1","Q1","1.59","34.62"%,
"Circulation-Cardiovascular Imaging","CIRC-CARDIOVASC IMAG","LIPPINCOTT WILLIAMS & WILKINS","1941-9651","1942-0080","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,805","7","Q1","1.83","15.76"%,
"BIODRUGS","BIODRUGS","ADIS INT LTD","1173-8804","1179-190X","ONCOLOGY","SCIE","3,460","6.9","Q1","1.16","48.84"%,
"Autism in Adulthood","AUTISM ADULTHOOD","MARY ANN LIEBERT, INC","2573-9581","2573-959X","REHABILITATION","SSCI","1,924","6.8","Q1","3.16","10"%,
"Clinical and Translational Medicine","CLIN TRANSL MED","JOHN WILEY & SONS LTD","2001-1326","2001-1326","ONCOLOGY","SCIE","9,628","6.8","Q1","1.56","98.5"%,
"BRITISH JOURNAL OF CANCER","BRIT J CANCER","SPRINGERNATURE","0007-0920","1532-1827","ONCOLOGY","SCIE","49,627","6.8","Q1","1.4","56.51"%,
"Circulation-Cardiovascular Quality and Outcomes","CIRC-CARDIOVASC QUAL","LIPPINCOTT WILLIAMS & WILKINS","1941-7705","1941-7713","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,657","6.7","Q1","1.51","9.61"%,
"European Heart Journal-Cardiovascular Imaging","EUR HEART J-CARD IMG","OXFORD UNIV PRESS","2047-2404","2047-2412","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","10,917","6.6","Q1","1.72","27.08"%,
"INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS","INT J RADIAT ONCOL","ELSEVIER SCIENCE INC","0360-3016","1879-355X","ONCOLOGY","SCIE","42,372","6.5","Q1","1.58","15.36"%,
"Pulmonology","PULMONOLOGY","TAYLOR & FRANCIS LTD","2531-0437","2531-0437","RESPIRATORY SYSTEM","SCIE","1,601","6.4","Q1","1.84","94.7"%,
"Oncogenesis","ONCOGENESIS","SPRINGERNATURE","2157-9024","2157-9024","ONCOLOGY","SCIE","4,427","6.4","Q1","1.29","100"%,
"RESPIROLOGY","RESPIROLOGY","WILEY","1323-7799","1440-1843","RESPIRATORY SYSTEM","SCIE","8,176","6.3","Q1","1.51","51.71"%,
"OncoImmunology","ONCOIMMUNOLOGY","TAYLOR & FRANCIS INC","2162-402X","2162-402X","ONCOLOGY","SCIE","15,331","6.3","Q1","1.36","99.75"%,
"Radiology-Imaging Cancer","RADIOL-IMAG CANCER","RADIOLOGICAL SOC NORTH AMERICA (RSNA)","2638-616X","2638-616X","ONCOLOGY","ESCI","713","6.3","Q1","1.16","97.53"%,
"Chinese Journal of Cancer Research","CHINESE J CANCER RES","CHINESE JOURNAL CANCER RESEARCH CO","1000-9604","1993-0631","ONCOLOGY","SCIE","2,673","6.3","Q1","0.96","100"%,
"Pneumonia","PNEUMONIA","BMC","2200-6133","2200-6133","RESPIRATORY SYSTEM","ESCI","521","6.2","Q1","1.29","98.11"%,
"European Heart Journal-Cardiovascular Pharmacotherapy","EUR HEART J-CARD PHA","OXFORD UNIV PRESS","2055-6837","2055-6845","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,006","6.1","Q1","1.61","24.18"%,
"JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE","J CARDIOVASC MAGN R","ELSEVIER SCIENCE INC","1097-6647","1532-429X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","6,904","6.1","Q1","1.41","100"%,
"Annual Review of Cancer Biology","ANNU REV CANCER BIOL","ANNUAL REVIEWS","2472-3428","2472-3428","ONCOLOGY","SCIE","1,041","6.1","Q1","0.97","93.1"%,
"JOURNAL OF HEART AND LUNG TRANSPLANTATION","J HEART LUNG TRANSPL","ELSEVIER SCIENCE INC","1053-2498","1557-3117","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","14,148","6","Q1","2.03","11.42"%,
"JOURNAL OF HEART AND LUNG TRANSPLANTATION","J HEART LUNG TRANSPL","ELSEVIER SCIENCE INC","1053-2498","1557-3117","RESPIRATORY SYSTEM","SCIE","14,148","6","Q1","2.03","11.42"%,
"Journal of Cystic Fibrosis","J CYST FIBROS","ELSEVIER","1569-1993","1873-5010","RESPIRATORY SYSTEM","SCIE","7,271","6","Q1","1.59","23.08"%,
"JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY","J AM SOC ECHOCARDIOG","MOSBY-ELSEVIER","0894-7317","N/A","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","12,523","6","Q1","1.54","13.89"%,
"Cancer Cell International","CANCER CELL INT","BMC","N/A","1475-2867","ONCOLOGY","SCIE","15,529","6","Q1","1.08","99.91"%,
"American Journal of Preventive Cardiology","AM J PREVENT CARDIOL","ELSEVIER","2666-6677","2666-6677","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,294","5.9","Q1","1.16","99.05"%,
"JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY","J ORTHOP SPORT PHYS","J O S P T","0190-6011","1938-1344","REHABILITATION","SCIE","10,490","5.8","Q1","2.12","2.22"%,
"HEART RHYTHM","HEART RHYTHM","ELSEVIER SCIENCE INC","1547-5271","1556-3871","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","15,509","5.8","Q1","1.55","20.31"%,
"Journal of Cardiovascular Computed Tomography","J CARDIOVASC COMPUT","ELSEVIER SCIENCE INC","1934-5925","1934-5925","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,289","5.8","Q1","1.47","23.7"%,
"PROSTATE CANCER AND PROSTATIC DISEASES","PROSTATE CANCER P D","SPRINGERNATURE","1365-7852","1476-5608","ONCOLOGY","SCIE","4,813","5.8","Q1","1.36","28.86"%,
"JCO Precision Oncology","JCO PRECIS ONCOL","LIPPINCOTT WILLIAMS & WILKINS","N/A","2473-4284","ONCOLOGY","SCIE","6,054","5.8","Q1","1.11","23.05"%,
"Cardiovascular Intervention and Therapeutics","CARDIOVASC INTERV TH","SPRINGER JAPAN KK","1868-4300","1868-4297","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,085","5.8","Q1","1.05","25"%,
"ATHEROSCLEROSIS","ATHEROSCLEROSIS","ELSEVIER IRELAND LTD","0021-9150","1879-1484","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","24,673","5.7","Q1","1.35","35.62"%,
"Cardiac Failure Review","CARD FAIL REV","RADCLIFFE CARDIOLOGY","2057-7540","2057-7559","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","997","5.7","Q1","1.09","100"%,
"BREAST CANCER RESEARCH","BREAST CANCER RES","BMC","1465-5411","1465-542X","ONCOLOGY","SCIE","12,611","5.6","Q1","1.3","100"%,
"CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY","CRIT REV ONCOL HEMAT","ELSEVIER SCIENCE INC","1040-8428","1879-0461","ONCOLOGY","SCIE","12,056","5.6","Q1","0.82","30.1"%,
"Circulation-Genomic and Precision Medicine","CIRC-GENOM PRECIS ME","LIPPINCOTT WILLIAMS & WILKINS","2574-8300","2574-8300","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,367","5.5","Q1","1.44","22.3"%,
"MOLECULAR CANCER THERAPEUTICS","MOL CANCER THER","AMER ASSOC CANCER RESEARCH","1535-7163","1538-8514","ONCOLOGY","SCIE","19,512","5.5","Q1","1.17","28.13"%,
"Annals of the American Thoracic Society","ANN AM THORAC SOC","AMER THORACIC SOC","2329-6933","2325-6621","RESPIRATORY SYSTEM","SCIE","11,308","5.4","Q1","1.62","11.06"%,
"Journal of the American Heart Association","J AM HEART ASSOC","WILEY","N/A","2047-9980","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","44,926","5.3","Q1","1.39","97.11"%,
"RADIOTHERAPY AND ONCOLOGY","RADIOTHER ONCOL","ELSEVIER IRELAND LTD","0167-8140","1879-0887","ONCOLOGY","SCIE","23,597","5.3","Q1","1.37","31.48"%,
"CANADIAN JOURNAL OF CARDIOLOGY","CAN J CARDIOL","ELSEVIER SCIENCE INC","0828-282X","1916-7075","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","10,339","5.3","Q1","1.34","15.53"%,
"Molecular Therapy Oncology","MOL THER ONCOL","CELL PRESS","N/A","2950-3299","ONCOLOGY","SCIE","3,963","5.3","Q1","1.23","97.95"%,
"AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY","AM J RESP CELL MOL","AMER THORACIC SOC","1044-1549","1535-4989","RESPIRATORY SYSTEM","SCIE","12,484","5.3","Q1","1.21","7.14"%,
"Cancer & Metabolism","CANCER METAB","BMC","N/A","2049-3002","ONCOLOGY","SCIE","1,546","5.3","Q1","1.08","100"%,
"IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING","IEEE T NEUR SYS REH","IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC","1534-4320","1558-0210","REHABILITATION","SCIE","16,219","5.2","Q1","1.96","99.83"%,
"JOURNAL OF PATHOLOGY","J PATHOL","WILEY","0022-3417","1096-9896","ONCOLOGY","SCIE","16,937","5.2","Q1","1.64","54.13"%,
"Journal of NeuroEngineering and Rehabilitation","J NEUROENG REHABIL","BMC","N/A","1743-0003","REHABILITATION","SCIE","10,023","5.2","Q1","1.51","100"%,
"BONE MARROW TRANSPLANTATION","BONE MARROW TRANSPL","SPRINGERNATURE","0268-3369","1476-5365","ONCOLOGY","SCIE","14,993","5.2","Q1","0.99","30.85"%,
"Cancer Drug Resistance","CANCER DRUG RESIST","OAE PUBLISHING INC","N/A","2578-532X","ONCOLOGY","ESCI","1,828","5.2","Q1","0.76","100"%,
"Oncology Reviews","ONCOL REV","FRONTIERS MEDIA SA","1970-5565","1970-5557","ONCOLOGY","ESCI","685","5.2","Q1","0.44","100"%,
"Gastric Cancer","GASTRIC CANCER","SPRINGER","1436-3291","1436-3305","ONCOLOGY","SCIE","7,538","5.1","Q1","1.21","42.59"%,
"CANCER","CANCER-AM CANCER SOC","WILEY","0008-543X","1097-0142","ONCOLOGY","SCIE","62,235","5.1","Q1","1.2","24.93"%,
"CANCER IMMUNOLOGY IMMUNOTHERAPY","CANCER IMMUNOL IMMUN","SPRINGER","0340-7004","1432-0851","ONCOLOGY","SCIE","13,329","5.1","Q1","1.08","64.57"%,
"RESPIRATORY RESEARCH","RESP RES","BMC","N/A","1465-993X","RESPIRATORY SYSTEM","SCIE","14,970","5","Q1","1.33","100"%,
"CANCER GENE THERAPY","CANCER GENE THER","SPRINGERNATURE","0929-1903","1476-5500","ONCOLOGY","SCIE","5,250","5","Q1","1.07","42"%,
"Current Oncology Reports","CURR ONCOL REP","SPRINGER","1523-3790","1534-6269","ONCOLOGY","SCIE","5,494","5","Q1","0.71","26.46"%,
"REVISTA ESPANOLA DE CARDIOLOGIA","REV ESP CARDIOL","EDICIONES DOYMA S A","N/A","1885-5857","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,058","4.9","Q1","2.08","8.33"%,
"INTERNATIONAL JOURNAL OF ONCOLOGY","INT J ONCOL","SPANDIDOS PUBL LTD","1019-6439","1791-2423","ONCOLOGY","SCIE","16,496","4.9","Q1","0.97","79.07"%,
"Blood and Lymphatic Cancer-Targets and Therapy","BLOOD LYMPHAT CANCER","DOVE MEDICAL PRESS LTD","1179-9889","1179-9889","ONCOLOGY","ESCI","183","4.9","Q1","0.6","96"%,
"CELLULAR ONCOLOGY","CELL ONCOL","SPRINGER","2211-3428","2211-3436","ONCOLOGY","SCIE","3,809","4.8","Q1","1.18","32.5"%,
"Cancer Nanotechnology","CANCER NANOTECHNOL","SPRINGER WIEN","1868-6958","1868-6966","ONCOLOGY","SCIE","1,343","4.8","Q1","0.91","100"%,
"npj Primary Care Respiratory Medicine","NPJ PRIM CARE RESP M","NATURE PORTFOLIO","N/A","2055-1010","RESPIRATORY SYSTEM","SCIE","1,448","4.7","Q1","1.42","100"%,
"INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER","INT J GYNECOL CANCER","BMJ PUBLISHING GROUP","1048-891X","1525-1438","ONCOLOGY","SCIE","10,505","4.7","Q1","1.32","14.35"%,
"INTERNATIONAL JOURNAL OF CANCER","INT J CANCER","WILEY","0020-7136","1097-0215","ONCOLOGY","SCIE","49,416","4.7","Q1","1.2","44.3"%,
"JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY","J MOL CELL CARDIOL","ELSEVIER SCI LTD","0022-2828","1095-8584","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","13,512","4.7","Q1","0.96","21.32"%,
"JCO Oncology Practice","JCO ONCOL PRACT","LIPPINCOTT WILLIAMS & WILKINS","2688-1527","2688-1535","ONCOLOGY","SCIE","4,261","4.7","Q1","0.9","9.03"%,
"MOLECULAR CANCER RESEARCH","MOL CANCER RES","AMER ASSOC CANCER RESEARCH","1541-7786","1557-3125","ONCOLOGY","SCIE","9,841","4.7","Q1","0.83","22.57"%,
"CURRENT TREATMENT OPTIONS IN ONCOLOGY","CURR TREAT OPTION ON","SPRINGER","1527-2729","1534-6277","ONCOLOGY","SCIE","3,770","4.7","Q1","0.62","28.91"%,
"Annals of Physical and Rehabilitation Medicine","ANN PHYS REHABIL MED","ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER","1877-0657","1877-0665","REHABILITATION","SCIE","3,435","4.6","Q1","1.68","27.39"%,
"European Heart Journal-Quality of Care and Clinical Outcomes","EUR HEART J-QUAL CAR","OXFORD UNIV PRESS","2058-5225","2058-1742","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,134","4.6","Q1","1.42","25.82"%,
"European Heart Journal-Acute Cardiovascular Care","EUR HEART J-ACUTE CA","OXFORD UNIV PRESS","2048-8726","2048-8734","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,167","4.6","Q1","1.12","22.88"%,
"CANCER BIOLOGY & THERAPY","CANCER BIOL THER","TAYLOR & FRANCIS INC","1538-4047","1555-8576","ONCOLOGY","SCIE","7,518","4.6","Q1","1.01","100"%,
"ENDOCRINE-RELATED CANCER","ENDOCR-RELAT CANCER","BIOSCIENTIFICA LTD","1351-0088","1479-6821","ONCOLOGY","SCIE","6,764","4.6","Q1","0.9","20.17"%,
"Molecular Oncology","MOL ONCOL","WILEY","1574-7891","1878-0261","ONCOLOGY","SCIE","10,219","4.5","Q2","1.04","100"%,
"CLINICS IN CHEST MEDICINE","CLIN CHEST MED","W B SAUNDERS CO-ELSEVIER INC","0272-5231","1557-8216","RESPIRATORY SYSTEM","SCIE","4,171","4.5","Q1","0.92","1.09"%,
"JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY","J THORAC CARDIOV SUR","MOSBY-ELSEVIER","0022-5223","1097-685X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","29,309","4.4","Q1","2.05","7.78"%,
"JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY","J THORAC CARDIOV SUR","MOSBY-ELSEVIER","0022-5223","1097-685X","RESPIRATORY SYSTEM","SCIE","29,309","4.4","Q1","2.05","7.78"%,
"HEART","HEART","BMJ PUBLISHING GROUP","1355-6037","1468-201X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","19,585","4.4","Q1","1.22","25.86"%,
"Clinical Epigenetics","CLIN EPIGENETICS","BMC","1868-7075","1868-7083","ONCOLOGY","SCIE","8,307","4.4","Q2","1.12","100"%,
"LUNG CANCER","LUNG CANCER","ELSEVIER IRELAND LTD","0169-5002","1872-8332","ONCOLOGY","SCIE","14,311","4.4","Q2","1.1","26.68"%,
"LUNG CANCER","LUNG CANCER","ELSEVIER IRELAND LTD","0169-5002","1872-8332","RESPIRATORY SYSTEM","SCIE","14,311","4.4","Q1","1.1","26.68"%,
"European Heart Journal - Digital Health","EUR HEART J-DIGIT HL","OXFORD UNIV PRESS","N/A","2634-3916","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","949","4.4","Q1","1.05","97.92"%,
"Cancers","CANCERS","MDPI","N/A","2072-6694","ONCOLOGY","SCIE","125,446","4.4","Q2","0.86","100"%,
"EXCEPTIONAL CHILDREN","EXCEPT CHILDREN","SAGE PUBLICATIONS INC","0014-4029","2163-5560","REHABILITATION","SSCI","2,932","4.3","Q1","2.38","9.09"%,
"CANCER SCIENCE","CANCER SCI","WILEY","1347-9032","1349-7006","ONCOLOGY","SCIE","20,374","4.3","Q2","1.01","96.48"%,
"Journal of Neurologic Physical Therapy","J NEUROL PHYS THER","LIPPINCOTT WILLIAMS & WILKINS","1557-0576","1557-0584","REHABILITATION","SCIE","1,735","4.2","Q1","1.52","11.11"%,
"HEART FAILURE REVIEWS","HEART FAIL REV","SPRINGER","1382-4147","1573-7322","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,160","4.2","Q1","1.07","29.43"%,
"ONCOLOGIST","ONCOLOGIST","OXFORD UNIV PRESS","1083-7159","1549-490X","ONCOLOGY","SCIE","18,262","4.2","Q2","0.97","100"%,
"Therapeutic Advances in Medical Oncology","THER ADV MED ONCOL","SAGE PUBLICATIONS LTD","1758-8340","1758-8359","ONCOLOGY","SCIE","5,012","4.2","Q2","0.8","99.3"%,
"Gynecologic Oncology","GYNECOL ONCOL","ACADEMIC PRESS INC ELSEVIER SCIENCE","0090-8258","1095-6859","ONCOLOGY","SCIE","25,448","4.1","Q2","1.32","17.11"%,
"AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY","AM J PHYSIOL-HEART C","AMER PHYSIOLOGICAL SOC","0363-6135","1522-1539","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","24,857","4.1","Q1","1.26","7.44"%,
"Translational Oncology","TRANSL ONCOL","ELSEVIER SCIENCE INC","1936-5233","1936-5233","ONCOLOGY","SCIE","7,809","4.1","Q2","1.05","99.25"%,
"Neuro-Oncology Advances","NEURO-ONCOL ADV","OXFORD UNIV PRESS","N/A","2632-2498","ONCOLOGY","ESCI","3,154","4.1","Q2","1.02","99.81"%,
"JNCI Cancer Spectrum","JNCI CANCER SPECT","OXFORD UNIV PRESS","N/A","2515-5091","ONCOLOGY","ESCI","2,313","4.1","Q2","0.89","98.54"%,
"ONCOLOGY RESEARCH","ONCOL RES","TECH SCIENCE PRESS","0965-0407","1555-3906","ONCOLOGY","SCIE","2,667","4.1","Q2","0.85","60.26"%,
"Recent Patents on Anti-Cancer Drug Discovery","RECENT PAT ANTI-CANC","BENTHAM SCIENCE PUBL LTD","1574-8928","2212-3970","ONCOLOGY","SCIE","1,149","4.1","Q2","0.71","4.73"%,
"Paediatric Respiratory Reviews","PAEDIATR RESPIR REV","ELSEVIER SCI LTD","1526-0542","1526-0550","RESPIRATORY SYSTEM","SCIE","2,354","4","Q1","1.54","25"%,
"ERJ Open Research","ERJ OPEN RES","EUROPEAN RESPIRATORY SOC JOURNALS LTD","N/A","2312-0541","RESPIRATORY SYSTEM","SCIE","5,723","4","Q1","0.98","96.67"%,
"Targeted Oncology","TARGET ONCOL","SPRINGER","1776-2596","1776-260X","ONCOLOGY","SCIE","2,512","4","Q2","0.92","43.72"%,
"ANNALS OF THORACIC SURGERY","ANN THORAC SURG","ELSEVIER SCIENCE INC","0003-4975","1552-6259","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","34,306","3.9","Q1","1.51","4.59"%,
"ANNALS OF THORACIC SURGERY","ANN THORAC SURG","ELSEVIER SCIENCE INC","0003-4975","1552-6259","RESPIRATORY SYSTEM","SCIE","34,306","3.9","Q1","1.51","4.59"%,
"European Journal of Cardiovascular Nursing","EUR J CARDIOVASC NUR","OXFORD UNIV PRESS","1474-5151","1873-1953","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,373","3.9","Q1","1.17","28.57"%,
"LUNG","LUNG","SPRINGER","0341-2040","1432-1750","RESPIRATORY SYSTEM","SCIE","3,791","3.9","Q1","1.15","35.14"%,
"ORAL ONCOLOGY","ORAL ONCOL","ELSEVIER","1368-8375","1879-0593","ONCOLOGY","SCIE","13,550","3.9","Q2","1.09","17.69"%,
"ONCOLOGY REPORTS","ONCOL REP","SPANDIDOS PUBL LTD","1021-335X","1791-2431","ONCOLOGY","SCIE","19,860","3.9","Q2","0.84","75.06"%,
"HEMATOLOGICAL ONCOLOGY","HEMATOL ONCOL","WILEY","0278-0232","1099-1069","ONCOLOGY","SCIE","2,507","3.9","Q2","0.58","36.43"%,
"Cancer Research and Treatment","CANCER RES TREAT","KOREAN CANCER ASSOCIATION","1598-2998","2005-9256","ONCOLOGY","SCIE","4,256","3.8","Q2","1.03","99.17"%,
"RESPIRATION","RESPIRATION","KARGER","0025-7931","1423-0356","RESPIRATORY SYSTEM","SCIE","5,421","3.8","Q1","0.9","20.61"%,
"Journal of Gastric Cancer","J GASTRIC CANCER","KOREAN GASTRIC CANCER ASSOC","2093-582X","2093-5641","ONCOLOGY","SCIE","1,007","3.8","Q2","0.84","26.47"%,
"Polish Heart Journal-Kardiologia Polska","POLISH HEART J","POLISH CARDIAC SOC","0022-9032","1897-4279","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,537","3.8","Q1","0.79","94.1"%,
"RESEARCH AND PRACTICE FOR PERSONS WITH SEVERE DISABILITIES","RES PRACT PERS SEV D","SAGE PUBLICATIONS INC","1540-7969","2169-2408","REHABILITATION","SSCI","1,103","3.7","Q1","1.97","13.21"%,
"ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION","ARCH PHYS MED REHAB","W B SAUNDERS CO-ELSEVIER INC","0003-9993","1532-821X","REHABILITATION","SCIE","26,392","3.7","Q1","1.57","10.81"%,
"NEUROREHABILITATION AND NEURAL REPAIR","NEUROREHAB NEURAL RE","SAGE PUBLICATIONS INC","1545-9683","1552-6844","REHABILITATION","SCIE","6,873","3.7","Q1","1.52","27.49"%,
"Journal of Gynecologic Oncology","J GYNECOL ONCOL","KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY","2005-0380","2005-0399","ONCOLOGY","SCIE","2,635","3.7","Q2","1.12","99.59"%,
"CIRCULATION JOURNAL","CIRC J","JAPANESE CIRCULATION SOC","1346-9843","1347-4820","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","10,246","3.7","Q1","0.97","97.37"%,
"Clinical Research in Cardiology","CLIN RES CARDIOL","SPRINGER HEIDELBERG","1861-0684","1861-0692","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,343","3.7","Q1","0.97","70.6"%,
"Cardiovascular Toxicology","CARDIOVASC TOXICOL","HUMANA PRESS INC","1530-7905","1559-0259","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,116","3.7","Q1","0.95","20.09"%,
"ESC Heart Failure","ESC HEART FAIL","WILEY PERIODICALS, INC","2055-5822","2055-5822","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","9,073","3.7","Q1","0.93","97.9"%,
"NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES","NUTR METAB CARDIOVAS","ELSEVIER SCI LTD","0939-4753","1590-3729","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","9,614","3.7","Q1","0.88","14.9"%,
"STEM CELLS","STEM CELLS","OXFORD UNIV PRESS","1066-5099","1549-4918","ONCOLOGY","SCIE","15,176","3.6","Q2","0.84","24.91"%,
"JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA","J MAMMARY GLAND BIOL","SPRINGER/PLENUM PUBLISHERS","1083-3021","1573-7039","ONCOLOGY","SCIE","1,805","3.6","Q2","0.83","77.05"%,
"European Cardiology Review","EUR CARDIOL REV","RADCLIFFE CARDIOLOGY","1758-3756","1758-3756","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,050","3.6","Q2","0.74","97.5"%,
"AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY","AM J PHYSIOL-LUNG C","AMER PHYSIOLOGICAL SOC","1040-0605","1522-1504","RESPIRATORY SYSTEM","SCIE","13,028","3.5","Q1","1.24","10.22"%,
"ANNALS OF SURGICAL ONCOLOGY","ANN SURG ONCOL","SPRINGER","1068-9265","1534-4681","ONCOLOGY","SCIE","34,088","3.5","Q2","1.22","20.82"%,
"AMERICAN HEART JOURNAL","AM HEART J","MOSBY-ELSEVIER","0002-8703","1097-6744","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","17,193","3.5","Q2","1.08","28.99"%,
"Practical Radiation Oncology","PRACT RADIAT ONCOL","ELSEVIER SCIENCE INC","1879-8500","1879-8500","ONCOLOGY","SCIE","3,428","3.5","Q2","1","6.19"%,
"CANCER IMAGING","CANCER IMAGING","BMC","1740-5025","1470-7330","ONCOLOGY","SCIE","3,462","3.5","Q2","0.98","100"%,
"PSYCHO-ONCOLOGY","PSYCHO-ONCOLOGY","WILEY","1057-9249","1099-1611","ONCOLOGY","SCIE","14,455","3.5","Q2","0.9","45.56"%,
"JTO Clinical and Research Reports","JTO CLIN RES REP","ELSEVIER","N/A","2666-3643","ONCOLOGY","ESCI","1,549","3.5","Q2","0.86","95.24"%,
"JTO Clinical and Research Reports","JTO CLIN RES REP","ELSEVIER","N/A","2666-3643","RESPIRATORY SYSTEM","ESCI","1,549","3.5","Q1","0.86","95.24"%,
"Translational Lung Cancer Research","TRANSL LUNG CANCER R","AME PUBLISHING COMPANY","2218-6751","2226-4477","ONCOLOGY","SCIE","6,087","3.5","Q2","0.84","100"%,
"Translational Lung Cancer Research","TRANSL LUNG CANCER R","AME PUBLISHING COMPANY","2218-6751","2226-4477","RESPIRATORY SYSTEM","SCIE","6,087","3.5","Q1","0.84","100"%,
"Frontiers of Medicine","FRONT MED-PRC","SPRINGER","2095-0217","2095-0225","ONCOLOGY","SCIE","3,083","3.5","Q2","0.82","4.72"%,
"Molecular Medicine Reports","MOL MED REP","SPANDIDOS PUBL LTD","1791-2997","1791-3004","ONCOLOGY","SCIE","26,534","3.5","Q2","0.78","80.85"%,
"Journal of Bone Oncology","J BONE ONCOL","ELSEVIER","N/A","2212-1374","ONCOLOGY","SCIE","1,510","3.5","Q2","0.7","100"%,
"MEDICAL ONCOLOGY","MED ONCOL","HUMANA PRESS INC","1357-0560","1559-131X","ONCOLOGY","SCIE","7,563","3.5","Q2","0.69","13.17"%,
"EXPERIMENTAL CELL RESEARCH","EXP CELL RES","ELSEVIER INC","0014-4827","1090-2422","ONCOLOGY","SCIE","20,027","3.5","Q2","0.66","18.32"%,
"CURRENT CANCER DRUG TARGETS","CURR CANCER DRUG TAR","BENTHAM SCIENCE PUBL LTD","1568-0096","1873-5576","ONCOLOGY","SCIE","3,277","3.5","Q2","0.53","5.1"%,
"European Journal of Physical and Rehabilitation Medicine","EUR J PHYS REHAB MED","EDIZIONI MINERVA MEDICA","1973-9087","1973-9095","REHABILITATION","SCIE","3,736","3.4","Q1","1.51","91.67"%,
"Current Heart Failure Reports","CURR HEART FAIL REP","SPRINGERNATURE","1546-9530","1546-9549","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,605","3.4","Q2","0.98","39.46"%,
"Journal of Breath Research","J BREATH RES","IOP Publishing Ltd","1752-7155","1752-7163","RESPIRATORY SYSTEM","SCIE","3,071","3.4","Q2","0.97","62.59"%,
"BMJ Open Respiratory Research","BMJ OPEN RESPIR RES","BMJ PUBLISHING GROUP","N/A","2052-4439","RESPIRATORY SYSTEM","SCIE","2,775","3.4","Q2","0.93","99.76"%,
"CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION","CANCER EPIDEM BIOMAR","AMER ASSOC CANCER RESEARCH","1055-9965","1538-7755","ONCOLOGY","SCIE","18,794","3.4","Q2","0.91","15.56"%,
"Cardiovascular Therapeutics","CARDIOVASC THER","WILEY","1755-5914","1755-5922","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,673","3.4","Q2","0.84","100"%,
"Journal of Hepatocellular Carcinoma","J HEPATOCELL CARCINO","DOVE MEDICAL PRESS LTD","N/A","2253-5969","ONCOLOGY","SCIE","2,130","3.4","Q2","0.8","100"%,
"BMC CANCER","BMC CANCER","BMC","N/A","1471-2407","ONCOLOGY","SCIE","47,055","3.4","Q2","0.79","99.98"%,
"Breast Cancer-Targets and Therapy","BREAST CANCER-TARGET","DOVE MEDICAL PRESS LTD","1179-1314","1179-1314","ONCOLOGY","SCIE","1,534","3.4","Q2","0.63","99.48"%,
"Current Oncology","CURR ONCOL","MDPI","1198-0052","1718-7729","ONCOLOGY","SCIE","9,445","3.4","Q2","0.63","100"%,
"Breathe","BREATHE","EUROPEAN RESPIRATORY SOC JOURNALS LTD","1810-6838","2073-4735","RESPIRATORY SYSTEM","ESCI","1,631","3.4","Q2","0.6","99.4"%,
"Physical Therapy","PHYS THER","OXFORD UNIV PRESS INC","0031-9023","1538-6724","REHABILITATION","SCIE","15,634","3.3","Q1","1.44","19.57"%,
"Disability and Health Journal","DISABIL HEALTH J","ELSEVIER SCIENCE INC","1936-6574","1876-7583","REHABILITATION","SCIE, SSCI","3,746","3.3","Q1","1.39","24.03"%,
"JOURNAL OF HEAD TRAUMA REHABILITATION","J HEAD TRAUMA REHAB","LIPPINCOTT WILLIAMS & WILKINS","0885-9701","1550-509X","REHABILITATION","SCIE, SSCI","4,866","3.3","Q1","1.36","11.42"%,
"Physics & Imaging in Radiation Oncology","PHYS IMAG RADIAT ONC","ELSEVIER","N/A","2405-6316","ONCOLOGY","ESCI","1,633","3.3","Q2","0.96","93.41"%,
"Clinical Lung Cancer","CLIN LUNG CANCER","CIG MEDIA GROUP, LP","1525-7304","1938-0690","ONCOLOGY","SCIE","4,508","3.3","Q2","0.78","14.62"%,
"CURRENT PROBLEMS IN CARDIOLOGY","CURR PROB CARDIOLOGY","MOSBY-ELSEVIER","0146-2806","1535-6280","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,911","3.3","Q2","0.76","12.24"%,
"Cancer Research Communications","CANCER RES COMMUN","AMER ASSOC CANCER RESEARCH","N/A","2767-9764","ONCOLOGY","ESCI","1,416","3.3","Q2","0.73","97.17"%,
"Arrhythmia & Electrophysiology Review","ARRHYTH ELECTROPHYSI","RADCLIFFE CARDIOLOGY","2050-3369","2050-3377","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","884","3.3","Q2","0.69","98.48"%,
"Lung Cancer-Targets and Therapy","LUNG CANCER-TARGETS","DOVE MEDICAL PRESS LTD","N/A","1179-2728","ONCOLOGY","ESCI","427","3.3","Q2","0.69","94.29"%,
"Frontiers in Oncology","FRONT ONCOL","FRONTIERS MEDIA SA","2234-943X","2234-943X","ONCOLOGY","SCIE","94,513","3.3","Q2","0.68","99.83"%,
"Current Cardiology Reports","CURR CARDIOL REP","SPRINGER","1523-3782","1534-3170","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,134","3.3","Q2","0.64","17.18"%,
"JCO Global Oncology","JCO GLOB ONCOL","LIPPINCOTT WILLIAMS & WILKINS","N/A","2687-8941","ONCOLOGY","ESCI","2,519","3.3","Q2","0.64","95.05"%,
"Clinical Medicine Insights-Cardiology","CLIN MED INSIGHTS-CA","SAGE PUBLICATIONS LTD","1179-5468","1179-5468","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","573","3.3","Q2","0.59","97.5"%,
"Current Hematologic Malignancy Reports","CURR HEMATOL MALIG R","CURRENT MEDICINE GROUP","1558-8211","1558-822X","ONCOLOGY","SCIE","1,303","3.3","Q2","0.44","18.39"%,
"Brazilian Journal of Physical Therapy","BRAZ J PHYS THER","ASSOCIACAO BRASILEIRA PESQUISA POS-GRADUACAO FISIOTERAPIA-ABRAPG-FT","1413-3555","1809-9246","REHABILITATION","SCIE","2,979","3.2","Q1","1.31","19.41"%,
"CANCER CYTOPATHOLOGY","CANCER CYTOPATHOL","WILEY","1934-662X","1934-6638","ONCOLOGY","SCIE","3,277","3.2","Q2","0.91","26.48"%,
"International Journal of Cardiology","INT J CARDIOL","ELSEVIER IRELAND LTD","0167-5273","1874-1754","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","31,491","3.2","Q2","0.89","20.99"%,
"Radiation Oncology","RADIAT ONCOL","BMC","N/A","1748-717X","ONCOLOGY","SCIE","9,129","3.2","Q2","0.89","100"%,
"Journal of Bronchology & Interventional Pulmonology","J BRONCHOL INTERN PU","LIPPINCOTT WILLIAMS & WILKINS","1944-6586","1948-8270","RESPIRATORY SYSTEM","ESCI","1,209","3.2","Q2","0.84","11.03"%,
"SEMINARS IN RADIATION ONCOLOGY","SEMIN RADIAT ONCOL","W B SAUNDERS CO-ELSEVIER INC","1053-4296","1532-9461","ONCOLOGY","SCIE","2,778","3.2","Q2","0.83","14.81"%,
"Cardio-Oncology","CARDIO-ONCOLOGY","BMC","N/A","2057-3804","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","613","3.2","Q2","0.78","100"%,
"Cardio-Oncology","CARDIO-ONCOLOGY","BMC","N/A","2057-3804","ONCOLOGY","ESCI","613","3.2","Q2","0.78","100"%,
"MOLECULAR CARCINOGENESIS","MOL CARCINOGEN","WILEY","0899-1987","1098-2744","ONCOLOGY","SCIE","6,135","3.2","Q2","0.73","15.6"%,
"Journal of Cancer","J CANCER","IVYSPRING INT PUBL","1837-9664","1837-9664","ONCOLOGY","SCIE","13,674","3.2","Q2","0.71","97.56"%,
"CLINICAL & EXPERIMENTAL METASTASIS","CLIN EXP METASTAS","SPRINGER","0262-0898","1573-7276","ONCOLOGY","SCIE","3,416","3.2","Q2","0.7","45.75"%,
"NAR Cancer","NAR CANCER","OXFORD UNIV PRESS","2632-8674","2632-8674","ONCOLOGY","ESCI","807","3.2","Q2","0.7","98.68"%,
"Clinical Colorectal Cancer","CLIN COLORECTAL CANC","CIG MEDIA GROUP, LP","1533-0028","1938-0674","ONCOLOGY","SCIE","2,310","3.2","Q2","0.69","14.72"%,
"Oncology and Therapy","ONCOL THER","SPRINGER","2366-1070","2366-1089","ONCOLOGY","ESCI","621","3.2","Q2","0.56","100"%,
"Journal of Immunotherapy and Precision Oncology","J IMMUNOTHER PRECIS","Innovative Healthcare Institute","2666-2345","2590-017X","ONCOLOGY","ESCI","233","3.2","Q2","0.52","89.86"%,
"World Journal of Clinical Oncology","WORLD J CLIN ONCOL","BAISHIDENG PUBLISHING GROUP INC","2218-4333","2218-4333","ONCOLOGY","ESCI","2,131","3.2","Q2","0.45","97.78"%,
"Annals of Cardiothoracic Surgery","ANN CARDIOTHORAC SUR","AME PUBLISHING COMPANY","2225-319X","2304-1021","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,667","3.1","Q2","1","100"%,
"RESPIRATORY MEDICINE","RESP MED","W B SAUNDERS CO LTD","0954-6111","1532-3064","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","13,738","3.1","Q2","0.91","26.76"%,
"RESPIRATORY MEDICINE","RESP MED","W B SAUNDERS CO LTD","0954-6111","1532-3064","RESPIRATORY SYSTEM","SCIE","13,738","3.1","Q2","0.91","26.76"%,
"Korean Circulation Journal","KOREAN CIRC J","KOREAN SOC CARDIOLOGY","1738-5520","1738-5555","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,986","3.1","Q2","0.83","26.58"%,
"JOURNAL OF NEURO-ONCOLOGY","J NEURO-ONCOL","SPRINGER","0167-594X","1573-7373","ONCOLOGY","SCIE","14,727","3.1","Q2","0.82","31.69"%,
"CARDIOVASCULAR DRUGS AND THERAPY","CARDIOVASC DRUG THER","SPRINGER","0920-3206","1573-7241","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,639","3.1","Q2","0.78","27.55"%,
"Journal of Cardiopulmonary Rehabilitation and Prevention","J CARDIOPULM REHABIL","LIPPINCOTT WILLIAMS & WILKINS","1932-7501","1932-751X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,552","3.1","Q2","0.77","6.11"%,
"Global Heart","GLOB HEART","UBIQUITY PRESS LTD","2211-8160","2211-8179","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,169","3.1","Q2","0.75","100"%,
"International Journal of Chronic Obstructive Pulmonary Disease","INT J CHRONIC OBSTR","DOVE MEDICAL PRESS LTD","1178-2005","1178-2005","RESPIRATORY SYSTEM","SCIE","9,044","3.1","Q2","0.75","99.71"%,
"INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE","INT J TUBERC LUNG D","INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)","1027-3719","1815-7920","RESPIRATORY SYSTEM","SCIE","6,076","3.1","Q2","0.73","23.31"%,
"Cancer Medicine","CANCER MED-US","WILEY","2045-7634","2045-7634","ONCOLOGY","SCIE","22,317","3.1","Q2","0.68","96.43"%,
"Tumori Journal","TUMORI J","SAGE PUBLICATIONS LTD","0300-8916","2038-2529","ONCOLOGY","SCIE","2,128","3.1","Q2","0.41","21.74"%,
"Physiotherapy","PHYSIOTHERAPY","ELSEVIER SCI LTD","0031-9406","1873-1465","REHABILITATION","SCIE","3,481","3","Q1","1.13","40.41"%,
"EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY","EUR J CARDIO-THORAC","OXFORD UNIV PRESS INC","1010-7940","1873-734X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","17,324","3","Q2","1.07","16.69"%,
"EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY","EUR J CARDIO-THORAC","OXFORD UNIV PRESS INC","1010-7940","1873-734X","RESPIRATORY SYSTEM","SCIE","17,324","3","Q2","1.07","16.69"%,
"JMIR Rehabilitation and Assistive Technologies","JMIR REHABIL ASSIST","JMIR PUBLICATIONS, INC","N/A","2369-2529","REHABILITATION","ESCI","782","3","Q1","1.04","97.41"%,
"SUPPORTIVE CARE IN CANCER","SUPPORT CARE CANCER","SPRINGER","0941-4355","1433-7339","ONCOLOGY","SCIE","23,978","3","Q2","0.99","32.93"%,
"SUPPORTIVE CARE IN CANCER","SUPPORT CARE CANCER","SPRINGER","0941-4355","1433-7339","REHABILITATION","SCIE","23,978","3","Q1","0.99","32.93"%,
"INTERNATIONAL JOURNAL OF HYPERTHERMIA","INT J HYPERTHER","TAYLOR & FRANCIS LTD","0265-6736","1464-5157","ONCOLOGY","SCIE","6,446","3","Q2","0.81","99.51"%,
"Therapeutic Advances in Respiratory Disease","THER ADV RESPIR DIS","SAGE PUBLICATIONS LTD","1753-4658","1753-4666","RESPIRATORY SYSTEM","SCIE","1,819","3","Q2","0.78","99.15"%,
"Journal of Asthma and Allergy","J ASTHMA ALLERGY","DOVE MEDICAL PRESS LTD","1178-6965","1178-6965","RESPIRATORY SYSTEM","SCIE","2,256","3","Q2","0.74","98.92"%,
"American Journal of Cardiovascular Drugs","AM J CARDIOVASC DRUG","ADIS INT LTD","1175-3277","1179-187X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,533","3","Q2","0.68","27.75"%,
"BREAST CANCER RESEARCH AND TREATMENT","BREAST CANCER RES TR","SPRINGER","0167-6806","1573-7217","ONCOLOGY","SCIE","21,736","3","Q2","0.66","39.09"%,
"CLINICAL ONCOLOGY","CLIN ONCOL-UK","ELSEVIER SCIENCE LONDON","0936-6555","1433-2981","ONCOLOGY","SCIE","4,662","3","Q2","0.66","20.89"%,
"Hellenic Journal of Cardiology","HELL J CARDIOL","ELSEVIER","1109-9666","2241-5955","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,194","3","Q2","0.66","100"%,
"Pulmonary Therapy","PULM THER","SPRINGERNATURE","2364-1754","2364-1746","RESPIRATORY SYSTEM","ESCI","485","3","Q2","0.66","100"%,
"Brain Tumor Pathology","BRAIN TUMOR PATHOL","SPRINGER JAPAN KK","1433-7398","1861-387X","ONCOLOGY","SCIE","849","3","Q2","0.65","19.67"%,
"Journal of Cardiovascular Aging","J CARDIOVASC AGING","OAE PUBLISHING INC","N/A","2768-5993","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","150","3","Q2","0.63","77.05"%,
"Tuberculosis and Respiratory Diseases","TUBERC RESPIR DIS","THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES","1738-3536","2005-6184","RESPIRATORY SYSTEM","ESCI","1,250","3","Q2","0.63","99.13"%,
"Therapeutic Advances in Pulmonary and Critical Care Medicine","THER ADV PULM CRIT C","SAGE PUBLICATIONS LTD","N/A","2976-8675","RESPIRATORY SYSTEM","ESCI","7","3","Q2","0.6","33.33"%,
"Anti-Cancer Agents in Medicinal Chemistry","ANTI-CANCER AGENT ME","BENTHAM SCIENCE PUBL LTD","1871-5206","1875-5992","ONCOLOGY","SCIE","6,048","3","Q2","0.59","2.9"%,
"Advances in Cancer Biology-Metastasis","ADV CANCER BIOL-MET","ELSEVIER","N/A","2667-3940","ONCOLOGY","ESCI","317","3","Q2","0.57","97.03"%,
"Jornal Brasileiro de Pneumologia","J BRAS PNEUMOL","SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA","1806-3713","1806-3756","RESPIRATORY SYSTEM","SCIE","2,378","3","Q2","0.55","99.34"%,
"International Journal of Breast Cancer","INT J BREAST CANCER","WILEY","2090-3170","2090-3189","ONCOLOGY","ESCI","561","3","Q2","0.49","100"%,
"JOURNAL OF LEARNING DISABILITIES","J LEARN DISABIL-US","SAGE PUBLICATIONS INC","0022-2194","1538-4780","REHABILITATION","SSCI","3,714","2.9","Q1","1.87","21.25"%,
"LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS","LANG SPEECH HEAR SER","AMER SPEECH-LANGUAGE-HEARING ASSOC","0161-1461","1558-9129","REHABILITATION","SSCI","3,277","2.9","Q1","1.39","8.4"%,
"Archives of Physiotherapy","ARCH PHYSIOTHER","ABOUTSCIENCE SRL","N/A","2057-0082","REHABILITATION","ESCI","485","2.9","Q1","1.22","100"%,
"CLINICAL REHABILITATION","CLIN REHABIL","SAGE PUBLICATIONS LTD","0269-2155","1477-0873","REHABILITATION","SCIE","8,752","2.9","Q1","1.17","29.18"%,
"EJSO","EJSO-EUR J SURG ONC","ELSEVIER SCI LTD","0748-7983","1532-2157","ONCOLOGY","SCIE","13,252","2.9","Q2","1.13","19.83"%,
"Annals of Rehabilitation Medicine-ARM","ANN REHABIL MED-ARM","KOREAN ACAD REHABILITATION MEDICINE","N/A","2234-0653","REHABILITATION","ESCI","2,134","2.9","Q1","0.98","99.18"%,
"Breast Cancer","BREAST CANCER-TOKYO","SPRINGER JAPAN KK","1340-6868","1880-4233","ONCOLOGY","SCIE","3,594","2.9","Q2","0.86","37.07"%,
"CARCINOGENESIS","CARCINOGENESIS","OXFORD UNIV PRESS","0143-3334","1460-2180","ONCOLOGY","SCIE","14,651","2.9","Q2","0.8","10.61"%,
"Journal of Cancer Survivorship","J CANCER SURVIV","SPRINGER","1932-2259","1932-2267","ONCOLOGY","SCIE","5,494","2.9","Q2","0.79","39.66"%,
"CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY","CARDIOVASC INTER RAD","SPRINGER","0174-1551","1432-086X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","7,319","2.9","Q2","0.77","32.87"%,
"CardioRenal Medicine","CARDIORENAL MED","KARGER","1664-3828","1664-5502","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","862","2.9","Q2","0.73","100"%,
"Frontiers in Cardiovascular Medicine","FRONT CARDIOVASC MED","FRONTIERS MEDIA SA","2297-055X","2297-055X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","29,172","2.9","Q2","0.72","99.82"%,
"Heart Rhythm O2","HEART RHYTHM O2","ELSEVIER","2666-5018","2666-5018","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","946","2.9","Q2","0.71","93.75"%,
"American Journal of Cancer Research","AM J CANCER RES","E-CENTURY PUBLISHING CORP","2156-6976","2156-6976","ONCOLOGY","SCIE","10,609","2.9","Q2","0.7","0.09"%,
"JOURNAL OF IMMUNOTHERAPY","J IMMUNOTHER","LIPPINCOTT WILLIAMS & WILKINS","1524-9557","1537-4513","ONCOLOGY","SCIE","3,215","2.9","Q2","0.67","26.76"%,
"Discover Oncology","DISCOV ONCOL","SPRINGER","N/A","2730-6011","ONCOLOGY","SCIE","1,590","2.9","Q2","0.65","99.84"%,
"Tuberculosis","TUBERCULOSIS","CHURCHILL LIVINGSTONE","1472-9792","1873-281X","RESPIRATORY SYSTEM","SCIE","3,636","2.9","Q2","0.51","25.88"%,
"BMC Sports Science Medicine and Rehabilitation","BMC SPORTS SCI MED R","BMC","2052-1847","2052-1847","REHABILITATION","SCIE","2,783","2.8","Q1","1.1","100"%,
"Games for Health Journal","GAMES HEALTH J","MARY ANN LIEBERT, INC","2161-783X","2161-7856","REHABILITATION","SSCI","1,797","2.8","Q1","0.97","1.2"%,
"Wearable Technologies","WEAR TECHNOL","CAMBRIDGE UNIV PRESS","N/A","2631-7176","REHABILITATION","ESCI","377","2.8","Q1","0.92","100"%,
"PM&R","PM&R","WILEY","1934-1482","1934-1563","REHABILITATION","SCIE","5,474","2.8","Q1","0.89","23.27"%,
"PULMONARY PHARMACOLOGY & THERAPEUTICS","PULM PHARMACOL THER","ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD","1094-5539","N/A","RESPIRATORY SYSTEM","SCIE","2,561","2.8","Q2","0.85","15.93"%,
"BMC Pulmonary Medicine","BMC PULM MED","BMC","1471-2466","1471-2466","RESPIRATORY SYSTEM","SCIE","9,617","2.8","Q2","0.77","99.94"%,
"GENES CHROMOSOMES & CANCER","GENE CHROMOSOME CANC","WILEY","1045-2257","1098-2264","ONCOLOGY","SCIE","4,708","2.8","Q2","0.72","38.74"%,
"Open Heart","OPEN HEART","BMJ PUBLISHING GROUP","2053-3624","2053-3624","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","3,505","2.8","Q2","0.7","100"%,
"Technical Innovations & Patient Support in Radiation Oncology","TECH INNOV PATIENT S","ELSEVIER","N/A","2405-6324","ONCOLOGY","ESCI","550","2.8","Q2","0.68","82.98"%,
"JCO Clinical Cancer Informatics","JCO CLIN CANCER INFO","LIPPINCOTT WILLIAMS & WILKINS","2473-4276","2473-4276","ONCOLOGY","ESCI","2,402","2.8","Q2","0.63","20.42"%,
"JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS","J CARDIOVASC PHARM T","SAGE PUBLICATIONS INC","1074-2484","1940-4034","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,491","2.8","Q2","0.63","98.68"%,
"INTEGRATIVE CANCER THERAPIES","INTEGR CANCER THER","SAGE PUBLICATIONS INC","1534-7354","1552-695X","ONCOLOGY","SCIE","3,532","2.8","Q2","0.62","98.58"%,
"Infectious Agents and Cancer","INFECT AGENTS CANCER","BMC","1750-9378","1750-9378","ONCOLOGY","SCIE","1,899","2.8","Q2","0.61","100"%,
"JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY","J CANCER RES CLIN","SPRINGER","0171-5216","1432-1335","ONCOLOGY","SCIE","13,878","2.8","Q2","0.61","50.59"%,
"International Journal of Clinical Oncology","INT J CLIN ONCOL","SPRINGER JAPAN KK","1341-9625","1437-7772","ONCOLOGY","SCIE","5,493","2.8","Q2","0.58","25.09"%,
"Interventional Cardiology-Reviews Research Resources","INTERV CARDIOL-REV R","RADCLIFFE CARDIOLOGY","1756-1477","1756-1485","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","228","2.8","Q2","0.58","95.77"%,
"OncoTargets and Therapy","ONCOTARGETS THER","DOVE MEDICAL PRESS LTD","1178-6930","1178-6930","ONCOLOGY","SCIE","14,107","2.8","Q2","0.56","99.65"%,
"TECHNOLOGY IN CANCER RESEARCH & TREATMENT","TECHNOL CANCER RES T","SAGE PUBLICATIONS INC","1533-0346","1533-0338","ONCOLOGY","SCIE","5,108","2.8","Q2","0.55","98.75"%,
"Structural Heart-The Journal of the Heart Team","STRUCT HEART","ELSEVIER SCIENCE INC","2474-8706","2474-8714","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","514","2.8","Q2","0.53","98.39"%,
"World Journal of Cardiology","WORLD J CARDIOL","BAISHIDENG PUBLISHING GROUP INC","1949-8462","1949-8462","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","2,045","2.8","Q2","0.52","98.8"%,
"Cancer Pathogenesis and Therapy","CANCER PATHOG THER","ELSEVIER","2097-2563","2949-7132","ONCOLOGY","ESCI","138","2.8","Q2","0.51","100"%,
"CURRENT OPINION IN PULMONARY MEDICINE","CURR OPIN PULM MED","LIPPINCOTT WILLIAMS & WILKINS","1070-5287","1531-6971","RESPIRATORY SYSTEM","SCIE","3,104","2.8","Q2","0.51","11.3"%,
"Expert Review of Anticancer Therapy","EXPERT REV ANTICANC","TAYLOR & FRANCIS LTD","1473-7140","1744-8328","ONCOLOGY","SCIE","4,123","2.8","Q2","0.51","6.6"%,
"European Journal of Oncology Nursing","EUR J ONCOL NURS","ELSEVIER SCI LTD","1462-3889","1532-2122","ONCOLOGY","SCIE","4,629","2.7","Q3","1","21.26"%,
"Clinical Genitourinary Cancer","CLIN GENITOURIN CANC","CIG MEDIA GROUP, LP","1558-7673","1938-0682","ONCOLOGY","SCIE","3,775","2.7","Q3","0.87","12.8"%,
"INVESTIGATIONAL NEW DRUGS","INVEST NEW DRUG","SPRINGER","0167-6997","1573-0646","ONCOLOGY","SCIE","5,612","2.7","Q3","0.76","34.2"%,
"Cardiovascular Digital Health Journal","CARDIOVASC DIGIT HLT","ELSEVIER","2666-6936","2666-6936","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","355","2.7","Q2","0.72","98.8"%,
"JOURNAL OF NUCLEAR CARDIOLOGY","J NUCL CARDIOL","ELSEVIER SCIENCE INC","1071-3581","1532-6551","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,099","2.7","Q2","0.72","27.94"%,
"Clinical and Translational Radiation Oncology","CLIN TRANSL RAD ONCO","ELSEVIER IRELAND LTD","N/A","2405-6308","ONCOLOGY","SCIE","2,244","2.7","Q3","0.71","94.81"%,
"Analytical Cellular Pathology","ANAL CELL PATHOL","WILEY","2210-7177","2210-7185","ONCOLOGY","SCIE","1,273","2.7","Q3","0.7","100"%,
"HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA","HEMATOL ONCOL CLIN N","W B SAUNDERS CO-ELSEVIER INC","0889-8588","1558-1977","ONCOLOGY","SCIE","3,379","2.7","Q3","0.67","1.27"%,
"Advances in Radiation Oncology","ADV RADIAT ONCOL","ELSEVIER INC","N/A","2452-1094","ONCOLOGY","ESCI","2,682","2.7","Q3","0.65","96.95"%,
"Journal of Geriatric Oncology","J GERIATR ONCOL","ELSEVIER","1879-4068","1879-4076","ONCOLOGY","SCIE","3,401","2.7","Q3","0.65","16.09"%,
"JMIR Cancer","JMIR CANCER","JMIR PUBLICATIONS, INC","2369-1999","2369-1999","ONCOLOGY","ESCI","987","2.7","Q3","0.64","96.91"%,
"Expert Review of Respiratory Medicine","EXPERT REV RESP MED","TAYLOR & FRANCIS LTD","1747-6348","1747-6356","RESPIRATORY SYSTEM","SCIE","3,218","2.7","Q2","0.63","9.78"%,
"Cardiology and Therapy","CARDIOL THER","SPRINGER LONDON LTD","2193-8261","2193-6544","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","712","2.7","Q2","0.61","100"%,
"SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE","SEMIN RESP CRIT CARE","THIEME MEDICAL PUBL INC","1069-3424","1098-9048","RESPIRATORY SYSTEM","SCIE","3,187","2.7","Q2","0.51","0.93"%,
"Clinical Lymphoma Myeloma & Leukemia","CL LYMPH MYELOM LEUK","CIG MEDIA GROUP, LP","2152-2650","2152-2669","ONCOLOGY","SCIE","4,175","2.7","Q3","0.49","20.36"%,
"Research in Developmental Disabilities","RES DEV DISABIL","PERGAMON-ELSEVIER SCIENCE LTD","0891-4222","1873-3379","REHABILITATION","SSCI","10,529","2.6","Q1","1.97","31.63"%,
"Journal of Cardiovascular Nursing","J CARDIOVASC NURS","LIPPINCOTT WILLIAMS & WILKINS","0889-4655","1550-5049","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,578","2.6","Q2","0.93","10.34"%,
"HEART & LUNG","HEART LUNG","MOSBY-ELSEVIER","0147-9563","1527-3288","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,783","2.6","Q2","0.91","11.27"%,
"HEART & LUNG","HEART LUNG","MOSBY-ELSEVIER","0147-9563","1527-3288","RESPIRATORY SYSTEM","SCIE","3,783","2.6","Q2","0.91","11.27"%,
"Journal of Cardiology","J CARDIOL","ELSEVIER","0914-5087","1876-4738","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,599","2.6","Q2","0.7","9.66"%,
"JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY","J CARDIOVASC ELECTR","WILEY","1045-3873","1540-8167","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","8,984","2.6","Q2","0.7","29.36"%,
"Pigment Cell & Melanoma Research","PIGM CELL MELANOMA R","WILEY","1755-1471","1755-148X","ONCOLOGY","SCIE","4,833","2.6","Q3","0.7","41.84"%,
"Cancer Genomics & Proteomics","CANCER GENOM PROTEOM","INT INST ANTICANCER RESEARCH","1109-6535","1790-6245","ONCOLOGY","SCIE","1,573","2.6","Q3","0.68","99.46"%,
"Photodiagnosis and Photodynamic Therapy","PHOTODIAGN PHOTODYN","ELSEVIER","1572-1000","1873-1597","ONCOLOGY","SCIE","9,810","2.6","Q3","0.66","33.28"%,
"Cancer Prevention Research","CANCER PREV RES","AMER ASSOC CANCER RESEARCH","1940-6207","1940-6215","ONCOLOGY","SCIE","4,759","2.6","Q3","0.64","15.08"%,
"JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY","J INTERV CARD ELECTR","SPRINGER","1383-875X","1572-8595","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,434","2.6","Q2","0.6","25.21"%,
"Future Oncology","FUTURE ONCOL","TAYLOR & FRANCIS LTD","1479-6694","1744-8301","ONCOLOGY","SCIE","7,830","2.6","Q3","0.57","40.39"%,
"Journal of Geriatric Cardiology","J GERIATR CARDIOL","TSINGHUA UNIV PRESS","1671-5411","1671-5411","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,311","2.6","Q2","0.57","1.81"%,
"Cancer Control","CANCER CONTROL","SAGE PUBLICATIONS INC","1073-2748","1526-2359","ONCOLOGY","SCIE","3,048","2.6","Q3","0.54","98.24"%,
"Cancer Management and Research","CANCER MANAG RES","DOVE MEDICAL PRESS LTD","1179-1322","1179-1322","ONCOLOGY","SCIE","11,206","2.6","Q3","0.52","99.82"%,
"AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY","AM J SPEECH-LANG PAT","AMER SPEECH-LANGUAGE-HEARING ASSOC","1058-0360","1558-9110","REHABILITATION","SCIE, SSCI","5,751","2.5","Q1","1.3","11.45"%,
"DYSLEXIA","DYSLEXIA","WILEY","1076-9242","1099-0909","REHABILITATION","SSCI","1,209","2.5","Q1","1.25","48.57"%,
"Topics in Stroke Rehabilitation","TOP STROKE REHABIL","TAYLOR & FRANCIS LTD","1074-9357","1945-5119","REHABILITATION","SCIE","3,078","2.5","Q1","1.02","9.9"%,
"Journal of Policy and Practice in Intellectual Disabilities","J POLICY PRACT INTEL","WILEY","1741-1122","1741-1130","REHABILITATION","SSCI","1,137","2.5","Q1","0.99","62.86"%,
"ASSISTIVE TECHNOLOGY","ASSIST TECHNOL","TAYLOR & FRANCIS INC","1040-0435","1949-3614","REHABILITATION","SSCI","1,582","2.5","Q1","0.96","16.11"%,
"CANCER NURSING","CANCER NURS","LIPPINCOTT WILLIAMS & WILKINS","0162-220X","1538-9804","ONCOLOGY","SCIE","4,739","2.5","Q3","0.94","5.33"%,
"World Journal of Surgical Oncology","WORLD J SURG ONCOL","BMC","N/A","1477-7819","ONCOLOGY","SCIE","9,000","2.5","Q3","0.93","100"%,
"Current Developmental Disorders Reports","CURR DEV DISORD REP","SPRINGERNATURE","N/A","2196-2987","REHABILITATION","ESCI","839","2.5","Q1","0.88","30.99"%,
"JOURNAL OF OCCUPATIONAL REHABILITATION","J OCCUP REHABIL","SPRINGER/PLENUM PUBLISHERS","1053-0487","1573-3688","REHABILITATION","SSCI","3,044","2.5","Q1","0.88","58.85"%,
"Seminars in Thoracic and Cardiovascular Surgery","SEMIN THORAC CARDIOV","ELSEVIER INC","1043-0679","1532-9488","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,104","2.5","Q2","0.83","7.21"%,
"Neuro-Oncology Practice","NEURO-ONCOL PRACT","OXFORD UNIV PRESS","2054-2577","2054-2585","ONCOLOGY","ESCI","1,331","2.5","Q3","0.68","33.02"%,
"STRAHLENTHERAPIE UND ONKOLOGIE","STRAHLENTHER ONKOL","SPRINGER HEIDELBERG","0179-7158","1439-099X","ONCOLOGY","SCIE","3,414","2.5","Q3","0.65","60.06"%,
"IJC Heart & Vasculature","IJC HEART VASC","ELSEVIER IRELAND LTD","N/A","2352-9067","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","2,377","2.5","Q2","0.64","99.61"%,
"Clinical Breast Cancer","CLIN BREAST CANCER","CIG MEDIA GROUP, LP","1526-8209","1938-0666","ONCOLOGY","SCIE","4,267","2.5","Q3","0.63","12.05"%,
"Cancer Informatics","CANCER INFORM","SAGE PUBLICATIONS LTD","N/A","1176-9351","ONCOLOGY","ESCI","825","2.5","Q3","0.62","98.96"%,
"Journal of Cardiovascular Translational Research","J CARDIOVASC TRANSL","SPRINGER","1937-5387","1937-5395","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,702","2.5","Q2","0.61","28.61"%,
"EUROPEAN HEART JOURNAL SUPPLEMENTS","EUR HEART J SUPPL","OXFORD UNIV PRESS","1520-765X","1554-2815","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,585","2.5","Q2","0.6","69.87"%,
"Pulmonary Circulation","PULM CIRC","WILEY","2045-8932","2045-8940","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,268","2.5","Q2","0.59","97.32"%,
"Pulmonary Circulation","PULM CIRC","WILEY","2045-8932","2045-8940","RESPIRATORY SYSTEM","SCIE","3,268","2.5","Q2","0.59","97.32"%,
"Clinical & Translational Oncology","CLIN TRANSL ONCOL","SPRINGER INT PUBL AG","1699-048X","1699-3055","ONCOLOGY","SCIE","5,617","2.5","Q3","0.57","22.58"%,
"EUROPEAN JOURNAL OF CANCER PREVENTION","EUR J CANCER PREV","LIPPINCOTT WILLIAMS & WILKINS","0959-8278","1473-5709","ONCOLOGY","SCIE","2,681","2.5","Q3","0.54","15.71"%,
"ACTA CARDIOLOGICA","ACTA CARDIOL","TAYLOR & FRANCIS LTD","0001-5385","1784-973X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,842","2.5","Q2","0.5","2.58"%,
"World Journal of Gastrointestinal Oncology","WORLD J GASTRO ONCOL","BAISHIDENG PUBLISHING GROUP INC","1948-5204","1948-5204","ONCOLOGY","SCIE","3,066","2.5","Q3","0.46","99.09"%,
"Oncologie","ONCOLOGIE","WALTER DE GRUYTER GMBH","1292-3818","1765-2839","ONCOLOGY","SCIE","532","2.5","Q3","0.39","88.24"%,
"SEMINARS IN ONCOLOGY","SEMIN ONCOL","W B SAUNDERS CO-ELSEVIER INC","0093-7754","1532-8708","ONCOLOGY","SCIE","4,421","2.5","Q3","0.38","14.58"%,
"Chinese Clinical Oncology","CHIN CLIN ONCOL","AME PUBLISHING COMPANY","2304-3865","2304-3873","ONCOLOGY","ESCI","1,327","2.5","Q3","0.32","100"%,
"AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION","AM J PHYS MED REHAB","LIPPINCOTT WILLIAMS & WILKINS","0894-9115","1537-7385","REHABILITATION","SCIE","7,499","2.4","Q1","1.01","6.33"%,
"Physical Therapy in Sport","PHYS THER SPORT","CHURCHILL LIVINGSTONE","1466-853X","N/A","REHABILITATION","SCIE","3,711","2.4","Q1","1","30.5"%,
"Surgical Oncology Clinics of North America","SURG ONCOL CLIN N AM","W B SAUNDERS CO-ELSEVIER INC","1055-3207","1558-5042","ONCOLOGY","SCIE","1,754","2.4","Q3","0.77","0"%,
"Echo Research and Practice","ECHO RES PRACT","SPRINGERNATURE","2055-0464","2055-0464","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","590","2.4","Q2","0.74","100"%,
"SURGICAL ONCOLOGY-OXFORD","SURG ONCOL","ELSEVIER SCI LTD","0960-7404","1879-3320","ONCOLOGY","SCIE","3,315","2.4","Q3","0.73","16.25"%,
"Pleura and Peritoneum","PLEURA PERITONEUM","WALTER DE GRUYTER GMBH","2364-7671","2364-768X","ONCOLOGY","ESCI","405","2.4","Q3","0.63","94.92"%,
"Cancer Treatment and Research Communications","CANCER TREAT RES COM","ELSEVIER","2468-2942","2468-2942","ONCOLOGY","ESCI","1,716","2.4","Q3","0.52","100"%,
"Journal of Breast Cancer","J BREAST CANCER","KOREAN BREAST CANCER SOC","1738-6756","2092-9900","ONCOLOGY","SCIE","1,472","2.4","Q3","0.51","100"%,
"NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL","NUTR CANCER","ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD","0163-5581","1532-7914","ONCOLOGY","SCIE","7,462","2.4","Q3","0.45","5.9"%,
"CURRENT OPINION IN ONCOLOGY","CURR OPIN ONCOL","LIPPINCOTT WILLIAMS & WILKINS","1040-8746","1531-703X","ONCOLOGY","SCIE","2,813","2.4","Q3","0.38","12.89"%,
"Hereditary Cancer in Clinical Practice","HERED CANCER CLIN PR","BMC","1731-2302","1897-4287","ONCOLOGY","SCIE","593","2.4","Q3","0.36","100"%,
"ANNALS OF DYSLEXIA","ANN DYSLEXIA","SPRINGER","0736-9387","1934-7243","REHABILITATION","SSCI","1,161","2.3","Q1","1.69","31.75"%,
"JOURNAL OF REHABILITATION MEDICINE","J REHABIL MED","FOUNDATION REHABILITATION INFORMATION","1650-1977","1651-2081","REHABILITATION","SCIE","6,003","2.3","Q1","0.97","97.64"%,
"Chiropractic & Manual Therapies","CHIROPR MAN THER","BMC","N/A","2045-709X","REHABILITATION","SCIE","1,129","2.3","Q1","0.88","100"%,
"PEDIATRIC PULMONOLOGY","PEDIATR PULM","WILEY","8755-6863","1099-0496","RESPIRATORY SYSTEM","SCIE","9,801","2.3","Q2","0.88","27.94"%,
"JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY","J ELECTROMYOGR KINES","ELSEVIER SCI LTD","1050-6411","1873-5711","REHABILITATION","SCIE","6,300","2.3","Q1","0.87","26.48"%,
"Seminars in Oncology Nursing","SEMIN ONCOL NURS","ELSEVIER SCIENCE INC","0749-2081","1878-3449","ONCOLOGY","SCIE","2,688","2.3","Q3","0.84","27.43"%,
"Chronic Respiratory Disease","CHRON RESP DIS","SAGE PUBLICATIONS LTD","1479-9723","1479-9731","RESPIRATORY SYSTEM","SCIE","1,468","2.3","Q2","0.78","97.71"%,
"UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS","UROL ONCOL-SEMIN ORI","ELSEVIER SCIENCE INC","1078-1439","1873-2496","ONCOLOGY","SCIE","7,101","2.3","Q3","0.72","11.39"%,
"PEDIATRIC BLOOD & CANCER","PEDIATR BLOOD CANCER","WILEY","1545-5009","1545-5017","ONCOLOGY","SCIE","15,923","2.3","Q3","0.69","23.43"%,
"PATHOLOGY & ONCOLOGY RESEARCH","PATHOL ONCOL RES","FRONTIERS MEDIA SA","1219-4956","1532-2807","ONCOLOGY","SCIE","3,695","2.3","Q3","0.68","100"%,
"Cancer Epidemiology","CANCER EPIDEMIOL","ELSEVIER SCI LTD","1877-7821","1877-783X","ONCOLOGY","SCIE","4,759","2.3","Q3","0.67","27.98"%,
"CANCER CHEMOTHERAPY AND PHARMACOLOGY","CANCER CHEMOTH PHARM","SPRINGER","0344-5704","1432-0843","ONCOLOGY","SCIE","9,031","2.3","Q3","0.64","32.82"%,
"Annals of Thoracic Medicine","ANN THORAC MED","WOLTERS KLUWER MEDKNOW PUBLICATIONS","1817-1737","1998-3557","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,066","2.3","Q2","0.62","100"%,
"Annals of Thoracic Medicine","ANN THORAC MED","WOLTERS KLUWER MEDKNOW PUBLICATIONS","1817-1737","1998-3557","RESPIRATORY SYSTEM","SCIE","1,066","2.3","Q2","0.62","100"%,
"BMC Cardiovascular Disorders","BMC CARDIOVASC DISOR","BMC","1471-2261","1471-2261","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","9,582","2.3","Q2","0.62","99.95"%,
"CLINICAL CARDIOLOGY","CLIN CARDIOL","WILEY","0160-9289","1932-8737","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,904","2.3","Q2","0.62","96.67"%,
"Journal of Cardiovascular Development and Disease","J CARDIOVASC DEV DIS","MDPI","N/A","2308-3425","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","3,818","2.3","Q2","0.61","100"%,
"Thoracic Cancer","THORAC CANCER","WILEY","1759-7706","1759-7714","ONCOLOGY","SCIE","6,581","2.3","Q3","0.58","94.52"%,
"Thoracic Cancer","THORAC CANCER","WILEY","1759-7706","1759-7714","RESPIRATORY SYSTEM","SCIE","6,581","2.3","Q2","0.58","94.52"%,
"CURRENT PROBLEMS IN CANCER","CURR PROB CANCER","MOSBY-ELSEVIER","0147-0272","1535-6345","ONCOLOGY","SCIE","1,482","2.3","Q3","0.53","16.25"%,
"Clinical Respiratory Journal","CLIN RESPIR J","WILEY","1752-6981","1752-699X","RESPIRATORY SYSTEM","SCIE","2,556","2.3","Q2","0.52","95.69"%,
"Advances in Respiratory Medicine","ADV RESPIR MED","MDPI","2451-4934","2543-6031","RESPIRATORY SYSTEM","ESCI","627","2.3","Q2","0.5","98.51"%,
"Cardiology in Review","CARDIOL REV","LIPPINCOTT WILLIAMS & WILKINS","1061-5377","1538-4683","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,456","2.3","Q2","0.43","4.79"%,
"REHABILITATION","REHABILITATION","GEORG THIEME VERLAG KG","0034-3536","1439-1309","REHABILITATION","SCIE","967","2.3","Q1","0.41","13.58"%,
"Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis","J ENV SCI HEAL C-TOX","TAYLOR & FRANCIS INC","2689-6583","2689-6591","ONCOLOGY","SCIE","187","2.3","Q3","0.4","0"%,
"Heart International","HEART INT","TOUCH MEDICAL MEDIA LTD","2036-2579","2036-2579","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","229","2.3","Q2","0.34","86.05"%,
"Musculoskeletal Science and Practice","MUSCULOSKEL SCI PRAC","ELSEVIER","2468-7812","2468-7812","REHABILITATION","SCIE","2,447","2.2","Q2","1.14","36.01"%,
"JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH","J SPEECH LANG HEAR R","AMER SPEECH-LANGUAGE-HEARING ASSOC","1092-4388","1558-9102","REHABILITATION","SCIE, SSCI","13,065","2.2","Q2","1.13","13.3"%,
"Disability and Rehabilitation-Assistive Technology","DISABIL REHABIL-ASSI","TAYLOR & FRANCIS INC","1748-3107","1748-3115","REHABILITATION","SSCI","3,564","2.2","Q2","0.89","19.73"%,
"SPINAL CORD","SPINAL CORD","SPRINGERNATURE","1362-4393","1476-5624","REHABILITATION","SCIE","7,388","2.2","Q2","0.8","23.28"%,
"ANTI-CANCER DRUGS","ANTI-CANCER DRUG","LIPPINCOTT WILLIAMS & WILKINS","0959-4973","1473-5741","ONCOLOGY","SCIE","4,204","2.2","Q3","0.6","21.63"%,
"JOURNAL OF THROMBOSIS AND THROMBOLYSIS","J THROMB THROMBOLYS","SPRINGER","0929-5305","1573-742X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,378","2.2","Q2","0.58","25.81"%,
"Heart Lung and Circulation","HEART LUNG CIRC","ELSEVIER SCIENCE INC","1443-9506","1444-2892","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,645","2.2","Q2","0.57","18.4"%,
"JOURNAL OF CARDIOVASCULAR PHARMACOLOGY","J CARDIOVASC PHARM","LIPPINCOTT WILLIAMS & WILKINS","0160-2446","1533-4023","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,644","2.2","Q2","0.56","16.87"%,
"Therapeutic Advances in Cardiovascular Disease","THER ADV CARDIO DIS","SAGE PUBLICATIONS LTD","1753-9447","1753-9455","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","741","2.2","Q2","0.55","98.21"%,
"Archives of Cardiovascular Diseases","ARCH CARDIOVASC DIS","ELSEVIER MASSON, CORP OFF","1875-2136","1875-2128","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,947","2.2","Q2","0.54","10.95"%,
"JMIR Cardio","JMIR CARDIO","JMIR PUBLICATIONS, INC","N/A","2561-1011","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","418","2.2","Q2","0.53","100"%,
"Radiology and Oncology","RADIOL ONCOL","SCIENDO","1318-2099","1581-3207","ONCOLOGY","SCIE","1,610","2.2","Q3","0.53","98.84"%,
"Oncology Letters","ONCOL LETT","SPANDIDOS PUBL LTD","1792-1074","1792-1082","ONCOLOGY","SCIE","24,003","2.2","Q3","0.52","98.56"%,
"ACTA ONCOLOGICA","ACTA ONCOL","Medical Journal Sweden AB","0284-186X","1651-226X","ONCOLOGY","SCIE","8,897","2.2","Q3","0.51","99.55"%,
"NEOPLASMA","NEOPLASMA","AEPRESS SRO","0028-2685","1338-4317","ONCOLOGY","SCIE","2,692","2.2","Q3","0.51","2.22"%,
"CURRENT CARDIOLOGY REVIEWS","CURR CARDIOL REV","BENTHAM SCIENCE PUBL LTD","1573-403X","1875-6557","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","2,179","2.2","Q2","0.49","5.65"%,
"LEUKEMIA RESEARCH","LEUKEMIA RES","PERGAMON-ELSEVIER SCIENCE LTD","0145-2126","1873-5835","ONCOLOGY","SCIE","5,072","2.2","Q3","0.47","15.16"%,
"World Journal of Oncology","WORLD J ONCOL","ELMER PRESS INC","1920-4531","1920-454X","ONCOLOGY","ESCI","1,566","2.2","Q3","0.46","97.41"%,
"Radiation Oncology Journal","RADIAT ONCOL J","KOREAN SOC THERAPEUTIC RADIOLOGY & ONCOLOGY","2234-3156","2234-3156","ONCOLOGY","ESCI","845","2.2","Q3","0.42","96.88"%,
"LEUKEMIA & LYMPHOMA","LEUKEMIA LYMPHOMA","TAYLOR & FRANCIS LTD","1042-8194","1029-2403","ONCOLOGY","SCIE","8,999","2.2","Q3","0.41","11.9"%,
"JAPANESE JOURNAL OF CLINICAL ONCOLOGY","JPN J CLIN ONCOL","OXFORD UNIV PRESS","0368-2811","1465-3621","ONCOLOGY","SCIE","5,556","2.2","Q3","0.4","19.64"%,
"Journal of Molecular and Cellular Cardiology Plus","J MOL CELL CARD PLUS","ELSEVIER","N/A","2772-9761","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","83","2.2","Q2","0.4","98.48"%,
"CANCER JOURNAL","CANCER J","LIPPINCOTT WILLIAMS & WILKINS","1528-9117","1540-336X","ONCOLOGY","SCIE","2,856","2.2","Q3","0.33","5.26"%,
"MedComm-Oncology","MEDCOMM-ONCOL","WILEY","2769-6448","2769-6448","ONCOLOGY","ESCI","124","2.2","Q3","0.32","98.63"%,
"Research in Autism Spectrum Disorders","RES AUTISM SPECT DIS","ELSEVIER SCI LTD","1750-9467","1878-0237","REHABILITATION","SSCI","5,852","2.1","Q2","1.12","31.28"%,
"International Journal of Telerehabilitation","INT J TELEREHABILITA","UNIV PITTSBURGH, UNIV LIBRARY SYSTEM","1945-2020","1945-2020","REHABILITATION","ESCI","657","2.1","Q2","1.06","100"%,
"JOURNAL OF COMMUNICATION DISORDERS","J COMMUN DISORD","ELSEVIER SCIENCE INC","0021-9924","1873-7994","REHABILITATION","SCIE, SSCI","2,885","2.1","Q2","1.02","19.62"%,
"INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS","INT J LANG COMM DIS","WILEY","1368-2822","1460-6984","REHABILITATION","SCIE, SSCI","4,013","2.1","Q2","0.91","57.62"%,
"APHASIOLOGY","APHASIOLOGY","ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD","0268-7038","1464-5041","REHABILITATION","SCIE, SSCI","4,379","2.1","Q2","0.79","24.17"%,
"AMERICAN JOURNAL OF OCCUPATIONAL THERAPY","AM J OCCUP THER","AMER OCCUPATIONAL THERAPY ASSOC, INC","0272-9490","1943-7676","REHABILITATION","SSCI","6,242","2.1","Q2","0.68","2.27"%,
"JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA","J CARDIOTHOR VASC AN","W B SAUNDERS CO-ELSEVIER INC","1053-0770","1532-8422","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","8,053","2.1","Q3","0.66","9.15"%,
"JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA","J CARDIOTHOR VASC AN","W B SAUNDERS CO-ELSEVIER INC","1053-0770","1532-8422","RESPIRATORY SYSTEM","SCIE","8,053","2.1","Q3","0.66","9.15"%,
"Respiratory Care","RESP CARE","MARY ANN LIEBERT, INC","0020-1324","1943-3654","RESPIRATORY SYSTEM","SCIE","7,195","2.1","Q3","0.63","0.58"%,
"AMERICAN JOURNAL OF CARDIOLOGY","AM J CARDIOL","EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC","0002-9149","1879-1913","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","31,933","2.1","Q3","0.59","12.43"%,
"CANCER CAUSES & CONTROL","CANCER CAUSE CONTROL","SPRINGER","0957-5243","1573-7225","ONCOLOGY","SCIE","7,231","2.1","Q3","0.59","29.66"%,
"Breast Care","BREAST CARE","KARGER","1661-3791","1661-3805","ONCOLOGY","SCIE","1,532","2.1","Q3","0.57","22.22"%,
"Cardiovascular Revascularization Medicine","CARDIOVASC REVASCULA","ELSEVIER INC","1553-8389","1878-0938","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","2,663","2.1","Q3","0.57","15.37"%,
"CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS","CANCER BIOTHER RADIO","MARY ANN LIEBERT, INC","1084-9785","1557-8852","ONCOLOGY","SCIE","2,258","2.1","Q3","0.56","6.02"%,
"Pulmonary Medicine","PULM MED","WILEY","2090-1836","2090-1844","RESPIRATORY SYSTEM","ESCI","608","2.1","Q3","0.56","100"%,
"Canadian Respiratory Journal","CAN RESPIR J","WILEY","1198-2241","1916-7245","RESPIRATORY SYSTEM","SCIE","1,591","2.1","Q3","0.55","100"%,
"COPD-Journal of Chronic Obstructive Pulmonary Disease","COPD","TAYLOR & FRANCIS INC","1541-2555","1541-2563","RESPIRATORY SYSTEM","SCIE","2,651","2.1","Q3","0.53","100"%,
"Interactive Cardiovascular and Thoracic Surgery","INTERACT CARDIOV TH","OXFORD UNIV PRESS","1569-9293","1569-9285","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,848","2.1","Q3","0.53","81.86"%,
"Interactive Cardiovascular and Thoracic Surgery","INTERACT CARDIOV TH","OXFORD UNIV PRESS","1569-9293","1569-9285","RESPIRATORY SYSTEM","SCIE","5,848","2.1","Q3","0.53","81.86"%,
"Cardiovascular Diagnosis and Therapy","CARDIOVASC DIAGN THE","AME PUBLISHING COMPANY","2223-3652","2223-3660","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,920","2.1","Q3","0.5","99.62"%,
"Cancer Genetics","CANCER GENET-NY","ELSEVIER SCIENCE INC","2210-7762","2210-7770","ONCOLOGY","SCIE","1,371","2.1","Q3","0.44","6.17"%,
"Expert Review of Cardiovascular Therapy","EXPERT REV CARDIOVAS","TAYLOR & FRANCIS INC","1477-9072","1744-8344","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","2,255","2.1","Q3","0.4","7.04"%,
"AJIDD-American Journal on Intellectual and Developmental Disabilities","AJIDD-AM J INTELLECT","AMER ASSOC INTELLECTUAL and DEVELOPMENTAL DISABILITIES-AAIDD","1944-7515","1944-7558","REHABILITATION","SSCI","1,437","2","Q2","1.21","1.01"%,
"JOURNAL OF INTELLECTUAL DISABILITY RESEARCH","J INTELL DISABIL RES","WILEY","0964-2633","1365-2788","REHABILITATION","SSCI","5,505","2","Q2","0.99","48.74"%,
"DISABILITY & SOCIETY","DISABIL SOC","ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD","0968-7599","1360-0508","REHABILITATION","SSCI","5,250","2","Q2","0.96","37.65"%,
"Archives of Rehabilitation Research and Clinical Translation","ARCH REHAB RES CLIN","ELSEVIER","2590-1095","2590-1095","REHABILITATION","ESCI","608","2","Q2","0.86","89.45"%,
"DISABILITY AND REHABILITATION","DISABIL REHABIL","TAYLOR & FRANCIS LTD","0963-8288","1464-5165","REHABILITATION","SCIE, SSCI","18,119","2","Q2","0.86","26.01"%,
"Physical Medicine and Rehabilitation Clinics of North America","PHYS MED REH CLIN N","W B SAUNDERS CO-ELSEVIER INC","1047-9651","1558-1381","REHABILITATION","SCIE","2,564","2","Q2","0.83","0"%,
"Cardiology Journal","CARDIOL J","VIA MEDICA","1897-5593","1898-018X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,908","2","Q3","0.65","97.55"%,
"Heart Failure Clinics","HEART FAIL CLIN","ELSEVIER SCIENCE INC","1551-7136","N/A","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,529","2","Q3","0.64","1.47"%,
"Respiratory Investigation","RESPIR INVESTIG","ELSEVIER","2212-5345","2212-5353","RESPIRATORY SYSTEM","ESCI","1,701","2","Q3","0.63","17.87"%,
"Chronic Obstructive Pulmonary Diseases-Journal of the COPD Foundation","COPD-J COPD FDN","COPD FOUNDATION","2372-952X","2372-952X","RESPIRATORY SYSTEM","SCIE","747","2","Q3","0.57","96.53"%,
"Sleep and Breathing","SLEEP BREATH","SPRINGER HEIDELBERG","1520-9512","1522-1709","RESPIRATORY SYSTEM","SCIE","5,656","2","Q3","0.56","20.1"%,
"JOURNAL OF RADIATION RESEARCH","J RADIAT RES","OXFORD UNIV PRESS","0449-3060","1349-9157","ONCOLOGY","SCIE","3,552","2","Q3","0.54","94.74"%,
"Journal of Cardiovascular Medicine","J CARDIOVASC MED","LIPPINCOTT WILLIAMS & WILKINS","1558-2027","1558-2035","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,124","2","Q3","0.53","8.64"%,
"International Journal of Particle Therapy","INT J PART THER","ELSEVIER","N/A","2331-5180","ONCOLOGY","ESCI","587","2","Q3","0.51","98.85"%,
"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","J CLIN TUBER OTH MYC","ELSEVIER","2405-5794","2405-5794","RESPIRATORY SYSTEM","ESCI","917","2","Q3","0.51","98.99"%,
"Journal of Breast Imaging","J BREAST IMAGING","OXFORD UNIV PRESS","2631-6110","2631-6129","ONCOLOGY","ESCI","729","2","Q3","0.5","7.79"%,
"Netherlands Heart Journal","NETH HEART J","BOHN STAFLEU VAN LOGHUM BV","1568-5888","1876-6250","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,734","2","Q3","0.5","99.3"%,
"Familial Cancer","FAM CANCER","SPRINGER","1389-9600","1573-7292","ONCOLOGY","SCIE","1,831","2","Q3","0.48","46.77"%,
"Breast Journal","BREAST J","WILEY","1075-122X","1524-4741","ONCOLOGY","SCIE","3,296","2","Q3","0.47","99.05"%,
"INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS","INT J BIOL MARKER","SAGE PUBLICATIONS LTD","0393-6155","1724-6008","ONCOLOGY","SCIE","1,263","2","Q3","0.46","100"%,
"CORONARY ARTERY DISEASE","CORONARY ARTERY DIS","LIPPINCOTT WILLIAMS & WILKINS","0954-6928","1473-5830","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,951","2","Q3","0.45","16.28"%,
"Journal of Gastrointestinal Oncology","J GASTROINTEST ONCOL","AME PUBLISHING COMPANY","2078-6891","2219-679X","ONCOLOGY","SCIE","4,128","2","Q3","0.45","99.29"%,
"Cancer Innovation","CANCER INNOV","WILEY","2770-9191","2770-9183","ONCOLOGY","ESCI","161","2","Q3","0.38","98.26"%,
"CURRENT OPINION IN CARDIOLOGY","CURR OPIN CARDIOL","LIPPINCOTT WILLIAMS & WILKINS","0268-4705","1531-7080","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,470","2","Q3","0.38","5.88"%,
"Reports of Practical Oncology and Radiotherapy","REP PRACT ONCOL RADI","VIA MEDICA","1507-1367","2083-4640","ONCOLOGY","ESCI","1,589","2","Q3","0.35","51.99"%,
"Prostate Cancer","PROSTATE CANCER-US","WILEY","2090-3111","2090-312X","ONCOLOGY","ESCI","273","2","Q3","0.23","100"%,
"International Journal of Speech-Language Pathology","INT J SPEECH-LANG PA","TAYLOR & FRANCIS LTD","1754-9507","1754-9515","REHABILITATION","SCIE, SSCI","2,182","1.9","Q2","0.81","25"%,
"JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES","J APPL RES INTELLECT","WILEY","1360-2322","1468-3148","REHABILITATION","SSCI","4,120","1.9","Q2","0.8","60.51"%,
"CARDIOVASCULAR PATHOLOGY","CARDIOVASC PATHOL","ELSEVIER SCIENCE INC","1054-8807","1879-1336","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,178","1.9","Q3","0.79","32.05"%,
"Frontiers in Rehabilitation Sciences","FRONT REHABIL SCI","FRONTIERS MEDIA SA","N/A","2673-6861","REHABILITATION","ESCI","1,159","1.9","Q2","0.78","100"%,
"Journal of Manual & Manipulative Therapy","J MAN MANIP THER","ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD","1066-9817","2042-6186","REHABILITATION","ESCI","1,540","1.9","Q2","0.78","6.43"%,
"JOURNAL OF SURGICAL ONCOLOGY","J SURG ONCOL","WILEY","0022-4790","1096-9098","ONCOLOGY","SCIE","11,846","1.9","Q3","0.68","21.77"%,
"EUROPEAN JOURNAL OF CANCER CARE","EUR J CANCER CARE","WILEY","0961-5423","1365-2354","ONCOLOGY","SCIE","4,882","1.9","Q3","0.65","62.63"%,
"EUROPEAN JOURNAL OF CANCER CARE","EUR J CANCER CARE","WILEY","0961-5423","1365-2354","REHABILITATION","SCIE, SSCI","4,882","1.9","Q2","0.65","62.63"%,
"JTCVS Techniques","JTCVS TECHNIQUES","ELSEVIER","2666-2507","2666-2507","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","987","1.9","Q3","0.61","98.54"%,
"JTCVS Open","JTCVS OPEN","ELSEVIER","N/A","2666-2736","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","909","1.9","Q3","0.58","99.16"%,
"JTCVS Open","JTCVS OPEN","ELSEVIER","N/A","2666-2736","RESPIRATORY SYSTEM","ESCI","909","1.9","Q3","0.58","99.16"%,
"CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS","CATHETER CARDIO INTE","WILEY","1522-1946","1522-726X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","10,334","1.9","Q3","0.57","21.77"%,
"Arquivos Brasileiros de Cardiologia","ARQ BRAS CARDIOL","ARQUIVOS BRASILEIROS CARDIOLOGIA","0066-782X","1678-4170","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,120","1.9","Q3","0.55","97.77"%,
"Cancer Biomarkers","CANCER BIOMARK","IOS PRESS","1574-0153","1875-8592","ONCOLOGY","SCIE","2,762","1.9","Q3","0.51","24.56"%,
"Journal of Thoracic Disease","J THORAC DIS","AME PUBLISHING COMPANY","2072-1439","2077-6624","RESPIRATORY SYSTEM","SCIE","16,742","1.9","Q3","0.5","99.77"%,
"MELANOMA RESEARCH","MELANOMA RES","LIPPINCOTT WILLIAMS & WILKINS","0960-8931","1473-5636","ONCOLOGY","SCIE","2,433","1.9","Q3","0.5","19.9"%,
"ATS Scholar","ATS SCHOLAR","AMER THORACIC SOC","N/A","2690-7097","RESPIRATORY SYSTEM","ESCI","416","1.9","Q3","0.46","93.18"%,
"CJC Open","CJC OPEN","ELSEVIER","2589-790X","2589-790X","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,239","1.9","Q3","0.46","94.9"%,
"Breast Cancer-Basic and Clinical Research","BREAST CANCER-BASIC","SAGE PUBLICATIONS LTD","1178-2234","1178-2234","ONCOLOGY","ESCI","685","1.9","Q3","0.43","98.33"%,
"CANCER INVESTIGATION","CANCER INVEST","TAYLOR & FRANCIS INC","0735-7907","1532-4192","ONCOLOGY","SCIE","2,418","1.9","Q3","0.37","6.84"%,
"Cancer Reports","CANCER REP-US","WILEY","N/A","2573-8348","ONCOLOGY","ESCI","1,670","1.9","Q3","0.37","91.92"%,
"Clinical Medicine Insights-Oncology","CLIN MED INSIGHTS-ON","SAGE PUBLICATIONS LTD","N/A","1179-5549","ONCOLOGY","SCIE","844","1.9","Q3","0.35","99.02"%,
"Journal of Kidney Cancer and VHL","J KIDNEY CANCER VHL","CODON PUBLICATIONS","2203-5826","2203-5826","ONCOLOGY","ESCI","272","1.9","Q3","0.34","98.68"%,
"Molecular & Cellular Oncology","MOL CELL ONCOL","TAYLOR & FRANCIS INC","N/A","2372-3556","ONCOLOGY","ESCI","1,035","1.9","Q3","0.22","96"%,
"Focus on Autism and Other Developmental Disabilities","FOCUS AUTISM DEV DIS","SAGE PUBLICATIONS INC","1088-3576","1538-4829","REHABILITATION","SSCI","1,329","1.8","Q2","1.04","4.29"%,
"Journal of Hand Therapy","J HAND THER","HANLEY & BELFUS-ELSEVIER INC","0894-1130","1545-004X","REHABILITATION","SCIE","2,728","1.8","Q2","1.01","10.04"%,
"Journal of Geriatric Physical Therapy","J GERIATR PHYS THER","LIPPINCOTT WILLIAMS & WILKINS","1539-8412","2152-0895","REHABILITATION","SCIE","1,715","1.8","Q2","0.81","4.82"%,
"Physiotherapy Research International","PHYSIOTHER RES INT","WILEY","1358-2267","1471-2865","REHABILITATION","ESCI","1,415","1.8","Q2","0.78","20.73"%,
"Australian Occupational Therapy Journal","AUST OCCUP THER J","WILEY","0045-0766","1440-1630","REHABILITATION","SCIE","1,897","1.8","Q2","0.74","70.06"%,
"Advances in Rehabilitation Science and Practice","ADV REHAB SCI PRAC","SAGE PUBLICATIONS LTD","2753-6351","2753-6351","REHABILITATION","ESCI","26","1.8","Q2","0.73","75"%,
"NEUROREHABILITATION","NEUROREHABILITATION","IOS PRESS","1053-8135","1878-6448","REHABILITATION","SCIE, SSCI","3,816","1.8","Q2","0.61","10.62"%,
"BRAIN INJURY","BRAIN INJURY","TAYLOR & FRANCIS LTD","0269-9052","1362-301X","REHABILITATION","SCIE, SSCI","6,900","1.8","Q2","0.6","13.65"%,
"Current Cardiovascular Risk Reports","CURR CARDIOVASC RISK","SPRINGER","1932-9520","1932-9563","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","581","1.8","Q3","0.58","16.92"%,
"Thoracic Surgery Clinics","THORAC SURG CLIN","W B SAUNDERS CO-ELSEVIER INC","1547-4127","1558-5069","RESPIRATORY SYSTEM","SCIE","1,435","1.8","Q3","0.54","0"%,
"JOURNAL OF CHEMOTHERAPY","J CHEMOTHERAPY","TAYLOR & FRANCIS LTD","1120-009X","1973-9478","ONCOLOGY","SCIE","1,827","1.8","Q4","0.49","3.7"%,
"Respiratory Medicine and Research","RESPIR MED RES-FRANC","ELSEVIER","N/A","2590-0412","RESPIRATORY SYSTEM","SCIE","400","1.8","Q3","0.49","20.45"%,
"EXPERIMENTAL LUNG RESEARCH","EXP LUNG RES","TAYLOR & FRANCIS INC","0190-2148","1521-0499","RESPIRATORY SYSTEM","SCIE","1,050","1.8","Q3","0.46","65.57"%,
"Journal of Aerosol Medicine and Pulmonary Drug Delivery","J AEROSOL MED PULM D","MARY ANN LIEBERT, INC","1941-2711","1941-2703","RESPIRATORY SYSTEM","SCIE","1,507","1.8","Q3","0.45","11.96"%,
"ONCOLOGY","ONCOLOGY-BASEL","KARGER","0030-2414","1423-0232","ONCOLOGY","SCIE","4,155","1.8","Q4","0.45","12.61"%,
"Brachytherapy","BRACHYTHERAPY","ELSEVIER SCIENCE INC","1538-4721","1873-1449","ONCOLOGY","SCIE","2,361","1.8","Q4","0.44","5.92"%,
"Acta Cardiologica Sinica","ACTA CARDIOL SIN","TAIWAN SOC CARDIOLOGY","1011-6842","1011-6842","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","959","1.8","Q3","0.43","0.58"%,
"CARDIOLOGY","CARDIOLOGY","KARGER","0008-6312","1421-9751","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,469","1.8","Q3","0.43","38.74"%,
"Cardiovascular Engineering and Technology","CARDIOVASC ENG TECHN","SPRINGER","1869-408X","1869-4098","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,142","1.8","Q3","0.42","22.56"%,
"American Heart Journal Plus: Cardiology Research and Practice","AM HEART J PLUS","ELSEVIER","N/A","2666-6022","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","580","1.8","Q3","0.41","99.71"%,
"Cardiology Research and Practice","CARDIOL RES PRACT","WILEY","2090-8016","2090-0597","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,317","1.8","Q3","0.41","99.17"%,
"AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS","AM J CLIN ONCOL-CANC","LIPPINCOTT WILLIAMS & WILKINS","0277-3732","1537-453X","ONCOLOGY","SCIE","4,308","1.8","Q4","0.39","11.34"%,
"Indian Heart Journal","INDIAN HEART J","ELSEVIER","0019-4832","2213-3763","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","2,325","1.8","Q3","0.39","99.24"%,
"Journal of Cancer Prevention","J CANCER PREV","KOREAN SOC CANCER PREVENTION","2288-3649","2288-3657","ONCOLOGY","ESCI","994","1.8","Q4","0.38","100"%,
"Journal of the Egyptian National Cancer Institute","J EGYPT NATL CANCER","SPRINGER","1110-0362","2589-0409","ONCOLOGY","ESCI","711","1.8","Q4","0.36","99.31"%,
"Clinical Advances in Hematology & Oncology","CLIN ADV HEMATOL ONC","MILLENNIUM MEDICAL PUBLISHING, INC","1543-0790","1543-0790","ONCOLOGY","ESCI","778","1.8","Q4","0.34","0"%,
"ONCOLOGY-NEW YORK","ONCOLOGY-NY","UBM MEDICA","0890-9091","2767-7389","ONCOLOGY","SCIE","1,454","1.8","Q4","0.33","0"%,
"SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES","SARCOIDOSIS VASC DIF","MATTIOLI 1885","1124-0490","N/A","RESPIRATORY SYSTEM","SCIE","1,366","1.8","Q3","0.28","0"%,
"Canadian Journal of Occupational Therapy-Revue Canadienne d Ergotherapie","CAN J OCCUP THER","SAGE PUBLICATIONS INC","0008-4174","1911-9828","REHABILITATION","SCIE, SSCI","1,453","1.7","Q2","0.84","52.53"%,
"REHABILITATION PSYCHOLOGY","REHABIL PSYCHOL","EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC","0090-5550","1939-1544","REHABILITATION","SSCI","2,470","1.7","Q2","0.76","31.01"%,
"PHYSICAL & OCCUPATIONAL THERAPY IN PEDIATRICS","PHYS OCCUP THER PEDI","TAYLOR & FRANCIS INC","0194-2638","1541-3144","REHABILITATION","SCIE, SSCI","1,556","1.7","Q2","0.71","8.4"%,
"Developmental Neurorehabilitation","DEV NEUROREHABIL","TAYLOR & FRANCIS INC","1751-8423","1751-8431","REHABILITATION","SCIE","1,477","1.7","Q2","0.62","12.39"%,
"Journal of Arrhythmia","J ARRYTHM","WILEY","1880-4276","1883-2148","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","1,565","1.7","Q3","0.48","93.87"%,
"JOURNAL OF INTERVENTIONAL CARDIOLOGY","J INTERV CARDIOL","WILEY","0896-4327","1540-8183","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,654","1.7","Q3","0.43","100"%,
"ANTICANCER RESEARCH","ANTICANCER RES","INT INST ANTICANCER RESEARCH","0250-7005","1791-7530","ONCOLOGY","SCIE","20,320","1.7","Q4","0.4","20.7"%,
"CHEMOTHERAPY","CHEMOTHERAPY","KARGER","0009-3157","1421-9794","ONCOLOGY","SCIE","1,509","1.7","Q4","0.38","8.7"%,
"PNEUMOLOGIE","PNEUMOLOGIE","GEORG THIEME VERLAG KG","0934-8387","1438-8790","RESPIRATORY SYSTEM","ESCI","826","1.7","Q3","0.38","5.79"%,
"European Journal of Breast Health","EUR J BREAST HEALTH","GALENOS PUBL HOUSE","N/A","2587-0831","ONCOLOGY","ESCI","647","1.7","Q4","0.35","100"%,
"Oncology Research and Treatment","ONCOL RES TREAT","KARGER","2296-5270","2296-5262","ONCOLOGY","SCIE","1,343","1.7","Q4","0.35","16.32"%,
"Translational Cancer Research","TRANSL CANCER RES","AME PUBLISHING COMPANY","2218-676X","2219-6803","ONCOLOGY","SCIE","4,891","1.7","Q4","0.32","99.91"%,
"Learning Disabilities Research & Practice","LEARN DISABIL RES PR","SAGE PUBLICATIONS INC","0938-8982","1540-5826","REHABILITATION","SSCI","1,044","1.6","Q2","1.24","19.7"%,
"Intellectual and Developmental Disabilities","INTELLECT DEV DISAB","AMER ASSOC INTELLECTUAL and DEVELOPMENTAL DISABILITIES-AAIDD","1934-9491","1934-9556","REHABILITATION","SSCI","1,406","1.6","Q2","1.15","0"%,
"TOPICS IN LANGUAGE DISORDERS","TOP LANG DISORD","LIPPINCOTT WILLIAMS & WILKINS","0271-8294","1550-3259","REHABILITATION","SSCI","978","1.6","Q2","0.94","0"%,
"JOURNAL OF EARLY INTERVENTION","J EARLY INTERVENTION","SAGE PUBLICATIONS INC","1053-8151","2154-3992","REHABILITATION","SSCI","1,001","1.6","Q2","0.91","11.11"%,
"Augmentative and Alternative Communication","AUGMENT ALTERN COMM","TAYLOR & FRANCIS LTD","0743-4618","1477-3848","REHABILITATION","SSCI","1,592","1.6","Q2","0.89","23.91"%,
"ADAPTED PHYSICAL ACTIVITY QUARTERLY","ADAPT PHYS ACT Q","HUMAN KINETICS PUBL INC","0736-5829","1543-2777","REHABILITATION","SCIE","1,402","1.6","Q2","0.86","4.72"%,
"Journal of Exercise Rehabilitation","J EXERC REHABIL","KOREAN SOC EXERCISE REHABILITATION","2288-176X","2288-1778","REHABILITATION","ESCI","1,510","1.6","Q2","0.69","100"%,
"RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY","RESP PHYSIOL NEUROBI","ELSEVIER","1569-9048","1878-1519","RESPIRATORY SYSTEM","SCIE","6,185","1.6","Q3","0.64","19.51"%,
"Geriatric Orthopaedic Surgery & Rehabilitation","GERIATR ORTHOP SURG","SAGE PUBLICATIONS INC","2151-4585","2151-4593","REHABILITATION","SCIE","1,373","1.6","Q2","0.62","94.44"%,
"CARDIOLOGY CLINICS","CARDIOL CLIN","W B SAUNDERS CO-ELSEVIER INC","0733-8651","1558-2264","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,593","1.6","Q3","0.56","1.42"%,
"Cardiovascular Ultrasound","CARDIOVASC ULTRASOUN","BMC","N/A","1476-7120","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,272","1.6","Q3","0.53","100"%,
"Hong Kong Journal of Occupational Therapy","HONG KONG J OCCUP TH","SAGE PUBLICATIONS LTD","1569-1861","1876-4398","REHABILITATION","SCIE","287","1.6","Q2","0.52","95.56"%,
"Revista Portuguesa de Cardiologia","REV PORT CARDIOL","ELSEVIER ESPANA SLU","0870-2551","0304-4750","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,198","1.6","Q3","0.48","100"%,
"Multidisciplinary Respiratory Medicine","MULTIDISCIP RESP MED","MATTIOLI 1885","1828-695X","2049-6958","RESPIRATORY SYSTEM","ESCI","1,019","1.6","Q3","0.41","95.06"%,
"American Journal of Translational Research","AM J TRANSL RES","E-CENTURY PUBLISHING CORP","1943-8141","1943-8141","ONCOLOGY","SCIE","12,734","1.6","Q4","0.39","0.09"%,
"Public Health Action","PUBLIC HEALTH ACTION","INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)","2220-8372","2220-8372","RESPIRATORY SYSTEM","ESCI","662","1.6","Q3","0.38","98.23"%,
"Hematology Transfusion and Cell Therapy","HEMATOL TRANSF CELL","ELSEVIER","2531-1379","2531-1379","ONCOLOGY","ESCI","776","1.6","Q4","0.37","99.44"%,
"Journal of Gastrointestinal Cancer","J GASTROINTEST CANC","SPRINGER","1941-6628","1941-6636","ONCOLOGY","ESCI","2,118","1.6","Q4","0.32","14.6"%,
"Asia-Pacific Journal of Clinical Oncology","ASIA-PAC J CLIN ONCO","WILEY","1743-7555","1743-7563","ONCOLOGY","SCIE","2,016","1.6","Q4","0.31","21.33"%,
"Journal of Special Education Technology","J SPEC EDUC TECHNOL","SAGE PUBLICATIONS INC","0162-6434","2381-3121","REHABILITATION","SSCI","880","1.5","Q2","1.05","5.79"%,
"JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES","J DEV PHYS DISABIL","SPRINGER/PLENUM PUBLISHERS","1056-263X","1573-3580","REHABILITATION","SSCI","1,555","1.5","Q2","0.93","26.71"%,
"Advances in Neurodevelopmental Disorders","ADV NEURODEV DISORD","SPRINGERNATURE","2366-7532","2366-7540","REHABILITATION","ESCI","531","1.5","Q2","0.87","35.96"%,
"International Journal of Art Therapy","INT J ART THER","TAYLOR & FRANCIS LTD","1745-4832","1745-4840","REHABILITATION","ESCI","381","1.5","Q2","0.75","23.61"%,
"Pediatric Physical Therapy","PEDIATR PHYS THER","LIPPINCOTT WILLIAMS & WILKINS","0898-5669","1538-005X","REHABILITATION","SCIE","1,601","1.5","Q2","0.72","2.05"%,
"JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION","J BACK MUSCULOSKELET","IOS PRESS","1053-8127","1878-6324","REHABILITATION","SCIE","2,648","1.5","Q2","0.7","6.38"%,
"Journal of Sport Rehabilitation","J SPORT REHABIL","HUMAN KINETICS PUBL INC","1056-6716","1543-3072","REHABILITATION","SCIE","3,117","1.5","Q2","0.69","0.94"%,
"PHYSIOTHERAPY THEORY AND PRACTICE","PHYSIOTHER THEOR PR","TAYLOR & FRANCIS INC","0959-3985","1532-5040","REHABILITATION","SCIE","3,906","1.5","Q2","0.69","14.95"%,
"OTJR-Occupational Therapy Journal of Research","OTJR-OCCUP THER J RE","SAGE PUBLICATIONS INC","1539-4492","1938-2383","REHABILITATION","SSCI","1,231","1.5","Q2","0.68","15.05"%,
"SEXUALITY AND DISABILITY","SEX DISABIL","SPRINGER","0146-1044","1573-6717","REHABILITATION","SSCI","1,240","1.5","Q2","0.67","26.15"%,
"ARTS IN PSYCHOTHERAPY","ART PSYCHOTHER","PERGAMON-ELSEVIER SCIENCE LTD","0197-4556","1873-5878","REHABILITATION","SSCI","1,802","1.5","Q2","0.66","19.8"%,
"Progress in Rehabilitation Medicine","PROG REHABIL MED","JAPANESE ASSOC REHABILITATION MEDICINE","N/A","2432-1354","REHABILITATION","ESCI","326","1.5","Q2","0.56","100"%,
"Journal of Cardiothoracic Surgery","J CARDIOTHORAC SURG","BMC","N/A","1749-8090","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,598","1.5","Q3","0.54","100"%,
"International Journal of Osteopathic Medicine","INT J OSTEOPATH MED","ELSEVIER SCI LTD","1746-0689","1878-0164","REHABILITATION","SCIE","597","1.5","Q2","0.51","8.55"%,
"INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING","INT J CARDIOVAS IMAG","SPRINGER","1569-5794","1875-8312","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","4,732","1.5","Q3","0.49","35.51"%,
"Journal of Pediatric Hematology-Oncology Nursing","J PEDIAT HEMAT ONC N","SAGE PUBLICATIONS INC","2752-7530","2752-7549","ONCOLOGY","SCIE","128","1.5","Q4","0.47","5.56"%,
"JOURNAL OF CARDIOVASCULAR SURGERY","J CARDIOVASC SURG","EDIZIONI MINERVA MEDICA","0021-9509","1827-191X","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,870","1.5","Q3","0.45","6.38"%,
"HEART AND VESSELS","HEART VESSELS","SPRINGER","0910-8327","1615-2573","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,969","1.5","Q3","0.41","18.7"%,
"Anatolian Journal of Cardiology","ANATOL J CARDIOL","KARE PUBL","2149-2263","2149-2271","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","1,810","1.5","Q3","0.38","93.18"%,
"CVIR Endovascular","CVIR ENDOVASC","SPRINGERNATURE","N/A","2520-8934","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","561","1.5","Q3","0.37","100"%,
"JRSM Cardiovascular Disease","JRSM CARDIOVASC DIS","SAGE PUBLICATIONS LTD","N/A","2048-0040","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","369","1.5","Q3","0.33","73.08"%,
"Journal of Echocardiography","J ECHOCARDIOGR","SPRINGER JAPAN KK","1349-0222","1880-344X","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","376","1.5","Q3","0.32","9.33"%,
"Heart and Mind","HEART MIND","WOLTERS KLUWER MEDKNOW PUBLICATIONS","2468-6476","2468-6484","CARDIAC & CARDIOVASCULAR SYSTEMS","ESCI","189","1.5","Q3","0.22","100"%,
"Career Development and Transition for Exceptional Individuals","CAREER DEV TRANSIT E","SAGE PUBLICATIONS INC","2165-1434","2165-1442","REHABILITATION","SSCI","875","1.4","Q3","1.17","4.35"%,
"Journal of Deaf Studies and Deaf Education","J DEAF STUD DEAF EDU","OXFORD UNIV PRESS","1081-4159","1465-7325","REHABILITATION","SSCI","1,938","1.4","Q3","1.16","23.31"%,
"JOURNAL OF FLUENCY DISORDERS","J FLUENCY DISORD","ELSEVIER SCIENCE INC","0094-730X","1873-801X","REHABILITATION","SCIE, SSCI","1,513","1.4","Q3","1.06","15.49"%,
"International Journal of Developmental Disabilities","INT J DEV DISABIL","TAYLOR & FRANCIS LTD","2047-3869","2047-3877","REHABILITATION","SSCI","1,267","1.4","Q3","1.04","10.09"%,
"Journal of Intellectual Disabilities","J INTELLECT DISABILI","SAGE PUBLICATIONS LTD","1744-6295","1744-6309","REHABILITATION","SSCI","1,136","1.4","Q3","0.96","33.76"%,
"Education and Treatment of Children","EDUC TREAT CHILD","SPRINGERNATURE","0748-8491","1934-8924","REHABILITATION","SSCI","974","1.4","Q3","0.9","9.38"%,
"Rehabilitation Process and Outcome","REHABIL PROCESS OUTC","SAGE PUBLICATIONS LTD","1179-5727","1179-5727","REHABILITATION","ESCI","75","1.4","Q3","0.82","100"%,
"JOURNAL OF BODYWORK AND MOVEMENT THERAPIES","J BODYW MOV THER","ELSEVIER","1360-8592","1532-9283","REHABILITATION","ESCI","4,145","1.4","Q3","0.63","9.44"%,
"Disabilities","DISABILITIES-BASEL","MDPI","N/A","2673-7272","REHABILITATION","ESCI","220","1.4","Q3","0.6","100"%,
"PEDIATRIC CARDIOLOGY","PEDIATR CARDIOL","SPRINGER","0172-0643","1432-1971","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","5,618","1.4","Q3","0.55","15.48"%,
"PROSTHETICS AND ORTHOTICS INTERNATIONAL","PROSTHET ORTHOT INT","WOLTERS KLUWER HEALTH","0309-3646","1746-1553","REHABILITATION","SCIE","2,720","1.4","Q3","0.54","10.11"%,
"JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS","J MANIP PHYSIOL THER","MOSBY-ELSEVIER","0161-4754","N/A","REHABILITATION","SCIE","3,398","1.4","Q3","0.47","6.84"%,
"European Clinical Respiratory Journal","EUR CLIN RESPIR J","TAYLOR & FRANCIS LTD","2001-8525","2001-8525","RESPIRATORY SYSTEM","ESCI","385","1.4","Q3","0.46","100"%,
"ONCOLOGY NURSING FORUM","ONCOL NURS FORUM","ONCOLOGY NURSING SOC","0190-535X","1538-0688","ONCOLOGY","SCIE","3,576","1.4","Q4","0.46","0.73"%,
"THORACIC AND CARDIOVASCULAR SURGEON","THORAC CARDIOV SURG","GEORG THIEME VERLAG KG","0171-6425","1439-1902","CARDIAC & CARDIOVASCULAR SYSTEMS","SCIE","2,141","1.4","Q3","0.46","17.56"%,
"THORACIC AND CARDIOVASCULAR SURGEON","THORAC CARDIOV SURG","GEORG THIEME VERLAG KG","0171-6425","1439-1902","RESPIRATORY SYSTEM","SCIE","2,141","1.4","Q3","0.46","17.56"%,
"Brain Impairment","BRAIN IMPAIR","CSIRO PUBLISHING","1443-9646","1839-5252","REHABILITATION","SCIE","552","1.4","Q3","0.4","63.64"%,
"Cancer Radiotherapie","CANCER RADIOTHER","ELSEVIER","1278-3218","1769-6658","ONCOLOGY","SCIE","1,277","1.4","Q4","0.37","7.87"%,

Copyright (c) 2025 Clarivate 
By exporting the selected data; you agree to the data usage policy set forth in the Terms of Use 
